"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL252556";"IDEBENONE";"4.0";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"FENOPROFEN";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL289620";"";"None";"457.58";"0";"2.88";"2";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccccc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL44246";"";"None";"473.58";"1";"2.59";"1";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"17.38";"0.32";"5.64";"5.86";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"2";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"3.07";"nM";"8.51";"";"";"UO_0000065";"2.00";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL41543";"";"None";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"None";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL324554";"";"None";"590.72";"2";"5.51";"2f (dihydropyridine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCCN2CCC(c3cccc(OC)c3)CC2)c1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"14.18";"0.27";"2.87";"6.88";"0";"CHEMBL756250";"Binding affinity against Neuropeptide Y receptor type 1 using I-PYY as a radioligand in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL491762";"";"None";"366.46";"1";"5.01";"(RS)-1";"CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)=C(O)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL997870";"Inhibition of human neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155895";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL521750";"";"None";"400.44";"0";"3.48";"2u";"Cn1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981716";"Inhibition of NPYY1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144170";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1493277";"";"None";"367.90";"1";"6.13";"SID17506246";"CC(Sc1ccc(Cl)cc1)C(=O)Nc1ccccc1-c1ccccc1";"IC50";"'='";"10300.0";"nM";"4.99";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1580409";"";"None";"430.34";"1";"5.26";"SID14729875";"CN1CCN(c2ccccc2NC(=O)c2ccc(-c3ccc(Cl)cc3Cl)o2)CC1";"IC50";"'='";"4465.0";"nM";"5.35";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1455508";"";"None";"392.50";"0";"4.00";"SID14718687";"Cc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3194054";"";"None";"538.63";"1";"3.05";"SID17508973";"COc1ccc(/C=N/NC(=O)CN(CCc2ccccc2)S(=O)(=O)c2ccc(NC(C)=O)cc2)cc1OC";"IC50";"'='";"10390.0";"nM";"4.98";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL299598";"";"None";"531.12";"2";"7.21";"2c";"CCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL392787";"";"None";"535.06";"2";"5.58";"14";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3C[C@@H]2CCNC[C@H]2F)CC1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"13.60";"0.26";"1.70";"14.63";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL7002";"CIGLITAZONE";"2.0";"333.45";"0";"3.93";"1";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL685";"MEBENDAZOLE";"4.0";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1412538";"";"None";"324.34";"0";"3.45";"SID3717588";"CCc1cc(-c2[nH]ncc2-c2ccc3c(c2)OCO3)c(O)cc1O";"IC50";"'='";"13260.0";"nM";"4.88";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1383610";"";"None";"308.34";"0";"2.51";"SID24781445";"Cc1ccc(COC(=O)c2nn(-c3ccccc3)nc2N)cc1";"IC50";"'='";"12050.0";"nM";"4.92";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1545205";"";"None";"323.39";"0";"4.54";"SID22408684";"CC(C)(C)NC(=O)c1oc2ccccc2c1COc1ccccc1";"IC50";"'='";"18900.0";"nM";"4.72";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1372488";"";"None";"258.30";"0";"3.09";"SID4261075";"Cc1nn(-c2ccccc2)c2sc(C(=O)O)cc12";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468639";"";"None";"346.43";"0";"4.59";"SID4257335";"CCCCOc1cccc(OCCCC)c1C(=O)Nc1cc(C)on1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL49795";"";"None";"503.07";"2";"6.43";"2a";"CCc1sc(CCc2cc(OC)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL51290";"";"None";"608.21";"2";"7.82";"2u";"CCc1sc(CCc2cc(OCCCc3cccnc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"13.46";"0.27";"0.37";"8.33";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL17441";"";"None";"307.40";"0";"3.03";"1";"NCCCCNc1nc(N)c2cc(-c3ccccc3)ccc2n1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"16.58";"0.30";"2.07";"5.67";"0";"CHEMBL755162";"Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL380654";"";"None";"537.10";"1";"3.98";"1j";"O=C1c2c(n(CC3CCNCC3)c3ccccc23)[C@H](Oc2ccc(Cl)cc2)CC1N1CCN(CCO)CC1";"IC50";"'='";"37.15";"nM";"7.43";"";"";"UO_0000065";"13.83";"0.27";"3.45";"10.62";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL444633";"RIFABUTIN";"4.0";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL27577";"SALICYLAMIDE";"2.0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL154111";"SALSALATE";"4.0";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4.0";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL12948";"SEMUSTINE";"3.0";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL262777";"VANCOMYCIN";"4.0";"1449.27";"None";"None";"vancomycin";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"LABETALOL";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909076";"";"None";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL14";"CARBACHOL";"4.0";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"BROMOCRIPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL6466";"COUMARIN";"4.0";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL457299";"MACROGOL";"4.0";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL311350";"PIROMIDIC ACID";"2.0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL239774";"";"None";"603.06";"2";"6.51";"22";"O=C(c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@@H]1F)N1CCN(CC(F)(F)F)CC1";"IC50";"'='";"9772.0";"nM";"5.01";"";"";"UO_0000065";"8.31";"0.16";"-1.50";"10.07";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL400631";"";"None";"565.09";"1";"4.94";"21";"O=C(c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@@H]1F)N1CCN(CCO)CC1";"IC50";"'='";"832.0";"nM";"6.08";"";"";"UO_0000065";"10.76";"0.21";"1.14";"8.69";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL124152";"";"None";"591.71";"1";"4.45";"BMS-189323";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"13.39";"0.25";"3.47";"6.34";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"RAPAMYCIN";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"-1.0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL77639";"";"None";"376.46";"1";"5.06";"32";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL40458";"";"None";"615.82";"2";"5.88";"31";"N=C(NCCCc1ccccc1)NCCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2ccccc2C1";"IC50";"";"";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL1201631";"INSULIN HUMAN";"4.0";"None";"None";"None";"INSULIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1643";"RIBAVIRIN";"4.0";"244.21";"0";"-3.01";"RIBAVIRIN";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL18016";"";"None";"419.49";"0";"2.85";"5";"COc1cc2nc(N3CCC(N4Cc5ccccc5C4=O)CC3)nc(N)c2cc1OC";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"10.06";"0.19";"1.37";"4.50";"0";"CHEMBL755162";"Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"Diazepam";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL41686";"";"None";"518.06";"1";"4.02";"27 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)N[C@H]1CCc2ccccc21";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"10.18";"0.19";"1.26";"4.39";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2079587";"STANOZOLOL";"4.0";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL364713";"NOSCAPINE";"4.0";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"SID90341342";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4.0";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"None";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL167991";"";"None";"537.73";"1";"3.65";"3, FR-230481";"COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL756254";"Compound was evaluated for the inhibitory activity against human Neuropeptide Y receptor type 1; not tested";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135229";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL350620";"";"None";"535.75";"1";"4.62";"2, FR-226928";"COc1ccc2c(c1)CC(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"9.37";"0.18";"0.40";"7.11";"0";"CHEMBL756253";"Compound was evaluated for the inhibitory activity against human Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135229";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL435169";"";"None";"552.51";"1";"4.68";"29 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N[C@H]1CCc2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL44246";"";"None";"473.58";"1";"2.59";"1";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL2113710";"";"None";"571.19";"2";"8.15";"2h";"CC/C=C\CCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"14.58";"0.29";"0.18";"9.76";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL163470";"";"None";"526.15";"2";"5.02";"2g";"O=S(=O)(NCCN1CCC(CNC2CCCc3ccc(Cl)cc3C2)CC1)c1cccc2ccccc12";"IC50";"'='";"8500.0";"nM";"5.07";"";"";"UO_0000065";"9.64";"0.19";"0.05";"8.25";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL51422";"";"None";"573.20";"2";"8.38";"2f";"CCCCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL77589";"";"None";"374.48";"1";"5.96";"40f";"CCC(Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1836317";"";"None";"423.63";"0";"3.98";"15, Lu AA33810";"CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837821";"Antagonist activity at human NPY1 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL496327";"";"None";"377.40";"0";"3.02";"5r";"COC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001158";"Binding affinity to NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL563011";"";"None";"359.46";"0";"2.75";"3b";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)oc1C";"IC50";"'='";"70000.0";"nM";"4.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL361273";"";"None";"599.74";"1";"4.51";"3c";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3C)CC2)NC#N)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.00";"0.26";"3.89";"5.85";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL154889";"";"None";"435.57";"0";"2.60";"5d";"Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cccs3)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL214707";"";"None";"1990.31";"None";"None";"38";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1514.0";"nM";"5.82";"";"";"UO_0000065";"2.92";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL305660";"EBASTINE";"4.0";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1237";"LISINOPRIL ANHYDROUS";"4.0";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL94";"PHYSOSTIGMINE";"4.0";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL193482";"ESTRIOL";"4.0";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL880";"FAMCICLOVIR";"4.0";"321.34";"0";"0.54";"SID170464774";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1.0";"371.82";"0";"3.10";"Berberine HCl";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1601669";"ALFACALCIDOL";"4.0";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL351508";"";"None";"521.73";"1";"4.38";"2n";"COc1ccc2c(c1)CC(CNC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"8.70";"0.17";"0.16";"6.42";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL438342";"";"None";"533.05";"2";"5.84";"18";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3CC2=C(F)CNCC2)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"13.82";"0.26";"1.53";"14.81";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238728";"";"None";"549.09";"2";"5.92";"15";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3C[C@@H]2CCN(C)C[C@H]2F)CC1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"12.79";"0.25";"1.10";"17.15";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL266077";"";"None";"1674.93";"None";"None";"NPY Ac 25-36";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"35000.0";"nM";"4.46";"";"";"UO_0000065";"2.66";"None";"None";"None";"0";"CHEMBL750757";"Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"CHEMBL3307551";"";"";""
"CHEMBL52325";"";"None";"557.16";"2";"7.60";"2k";"CCc1sc(CCc2cc(OCC3(C)CC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.94";"0.28";"0.17";"9.10";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL395640";"";"None";"575.13";"2";"6.45";"17";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3C[C@@H]2CCN(C3CC3)C[C@@H]2F)CC1";"IC50";"'='";"186.0";"nM";"6.73";"";"";"UO_0000065";"11.70";"0.22";"0.28";"16.44";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL417912";"";"None";"561.15";"2";"6.83";"2j";"CCc1sc(CCc2cc(OC(C)COC)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"14.39";"0.29";"1.25";"8.54";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL43710";"";"None";"497.64";"0";"3.54";"3";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCCc2ccccc2C1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL551197";"";"None";"373.48";"0";"3.00";"3a";"CCc1oc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)nc1C";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL42861";"";"None";"573.74";"1";"4.74";"24";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)N1CCCc2ccccc2C1";"IC50";"'='";"51000.0";"nM";"4.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.871";"nM";"9.06";"";"";"UO_0000065";"14.71";"0.27";"6.81";"4.84";"0";"CHEMBL3750350";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 1 min by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1539";"SULFADOXINE";"4.0";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL62193";"SULFADIMETHOXINE";"4.0";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1747";"TOBRAMYCIN";"4.0";"467.52";"2";"-6.30";"TOB";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3215298";"ABAMECTIN";"3.0";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL4649901";"";"None";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1752";"DYPHYLLINE";"4.0";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"TACRINE";"Nc1c2c(nc3ccccc13)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"NIACINAMIDE";"NC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL49795";"";"None";"503.07";"2";"6.43";"2a";"CCc1sc(CCc2cc(OC)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"234.0";"nM";"6.63";"";"";"UO_0000065";"13.18";"0.27";"0.20";"7.77";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1836314";"";"None";"535.76";"2";"6.56";"12";"O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1837821";"Antagonist activity at human NPY1 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL299598";"";"None";"531.12";"2";"7.21";"2c";"CCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.63";"0.29";"0.56";"9.10";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL895";"NALBUPHINE";"4.0";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL940";"GABAPENTIN";"4.0";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"CISAPRIDE";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200406";"DIMENHYDRINATE";"4.0";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL36715";"PIRACETAM";"4.0";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL45";"MELATONIN";"4.0";"232.28";"0";"1.86";"Melatonin";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL238729";"";"None";"517.07";"2";"5.63";"16";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3CC2CCCNC2)CC1";"IC50";"'='";"107.0";"nM";"6.97";"";"";"UO_0000065";"13.48";"0.26";"1.34";"14.01";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL1651906";"STREPTOZOCIN";"4.0";"265.22";"0";"-2.89";"STREPTOZOTOCIN";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1.0";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL428992";"";"None";"1917.26";"None";"None";"24";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1248.0";"nM";"5.90";"";"";"UO_0000065";"3.08";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL384306";"";"None";"1940.29";"None";"None";"39";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL38531";"";"None";"516.60";"2";"1.61";"16 (R)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](C(N)=O)c1ccc(O)cc1";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL582790";"";"None";"429.52";"0";"3.96";"2a";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3ccc(F)nc3)n2)oc1C";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.88";"0.35";"3.72";"10.06";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL566441";"";"None";"477.59";"0";"3.36";"4a";"Cc1nc(SCc2cc(N3CCS(=O)(=O)CC3)cc(NCc3cccc(F)n3)n2)oc1C";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.95";"0.35";"4.74";"8.00";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL566041";"";"None";"441.63";"0";"4.60";"2l";"Cc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc(C)c(C)s3)n2)n1";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"21.67";"0.44";"4.97";"15.15";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1407754";"";"None";"298.30";"0";"3.29";"SID863245";"COc1ccc(Oc2c[nH]nc2-c2ccc(O)cc2O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL77276";"";"None";"390.48";"1";"5.58";"40j";"COc1ccc(CC(C)N(C)C(=O)Nc2ccc(Oc3ccccc3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL556183";"";"None";"355.44";"0";"2.50";"2f";"CCc1oc(CCc2cc(N3CCOCC3)cc(NCC#N)n2)nc1C";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL564536";"";"None";"572.18";"2";"6.81";"1";"CCc1sc(CCc2cc(N3CCOCC3)cc(NC(C)c3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL189412";"";"None";"610.72";"1";"4.08";"3e";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3C#N)CC2)NC#N)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"13.96";"0.26";"4.44";"5.09";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL187925";"";"None";"631.80";"1";"4.93";"3j";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3SC)CC2)NC#N)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"13.49";"0.26";"3.59";"5.94";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL366340";"";"None";"606.68";"1";"4.40";"6b";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3[N+](=O)[O-])CC2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.34";"0.27";"4.30";"5.19";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL306277";"";"None";"390.48";"0";"4.85";"44e";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(OCc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL429905";"";"None";"1899.24";"None";"None";"33";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL468";"THALIDOMIDE";"4.0";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1528149";"";"None";"563.68";"2";"3.99";"SID14724432";"COC(=O)C1=C(C(=O)OC)SC2(S1)C(C(=O)OC)=C(C(=O)OC)SC1=C2c2cccc(C)c2NC1(C)C";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL440735";"";"None";"506.05";"1";"4.10";"6c";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC1)c1cc2ccccc2s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"14, BIBP-3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"3.631";"nM";"8.44";"";"";"UO_0000065";"17.82";"0.33";"6.06";"5.91";"0";"CHEMBL1011807";"Displacement of [3H]UR-MK114 from neuropeptide Y1 receptor in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151759";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307551";"";"";""
"CHEMBL1511420";"";"None";"442.50";"0";"2.77";"SID22411498";"COc1ccc(NC(=O)c2nnc(O)c3ccccc23)cc1S(=O)(=O)N1CCCCC1";"IC50";"'='";"21010.0";"nM";"4.68";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1404069";"";"None";"415.45";"0";"4.60";"SID4242079";"COc1cccc(-c2nc(-c3ccc(NC(=O)Cc4ccccc4OC)cc3)no2)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585445";"";"None";"330.77";"0";"4.29";"SID7966598";"COc1ccc(-c2noc(COc3ccc(Cl)c(C)c3)n2)cc1";"IC50";"'='";"5137.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"Fluvastatin";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL153479";"AMBROXOL";"3.0";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1754";"DOXAPRAM";"4.0";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1454946";"FLUBENDAZOLE";"2.0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL433257";"HARRINGTONINE";"None";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1194";"PRILOCAINE";"4.0";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"None";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4.0";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL918";"PHENACEMIDE";"4.0";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"ENOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4.0";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1235242";"";"None";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL267345";"AMPHOTERICIN B";"4.0";"924.09";"3";"0.71";"AMPHOTERICIN B";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL87285";"ANDROSTERONE";"None";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"CARMUSTINE";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL614";"PYRAZINAMIDE";"4.0";"123.11";"0";"-0.42";"SID17389747";"NC(=O)c1cnccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL461727";"AMYGDALIN";"None";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1499";"CORTISONE";"3.0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1230333";"";"None";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200585";"OXYMETHOLONE";"4.0";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1487";"ATORVASTATIN";"4.0";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL418971";"BISPHENOL A";"None";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL442";"ERGOTAMINE";"4.0";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1527608";"DOXOFYLLINE";"3.0";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL428880";"CROMOLYN";"4.0";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"73, Phenytoin";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL290175";"";"None";"631.82";"2";"5.38";"32";"N/C(=N/CCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2cc(O)ccc2C1)NCCCc1ccccc1";"IC50";"'='";"11900.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL1427664";"";"None";"226.11";"0";"0.26";"SID855511";"CC(=O)OCC[N+](C)(C)C.[Br-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2004475";"";"None";"528.65";"1";"3.83";"SID24841448";"C/C1=C/[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@]32C(=O)/C=C\C(=O)[C@@H]1O";"IC50";"'='";"10590.0";"nM";"4.97";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1546304";"";"None";"367.41";"0";"2.93";"SID24786472";"Cn1ccnc1C1CCCCN1Cc1nc(-c2ccc3c(c2)OCO3)no1";"IC50";"'<'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1407634";"";"None";"447.22";"1";"5.58";"SID14729000";"Cc1c(OCc2c(F)cccc2Cl)c(=O)ccn1-c1ncc(C(F)(F)F)cc1Cl";"IC50";"'='";"6748.0";"nM";"5.17";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1414494";"";"None";"416.52";"0";"4.45";"SID24796623";"CC1=CC(C)(C)N(C(=O)CNC2CCCCC2)c2cc(C)ccc21.O=C(O)C(=O)O";"IC50";"'='";"6837.0";"nM";"5.17";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1336318";"";"None";"335.79";"1";"5.17";"SID14737419";"O=C(c1ccco1)c1cn(Cc2ccc(Cl)cc2)c2ccccc12";"IC50";"'='";"6687.0";"nM";"5.17";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1771261";"";"None";"492.45";"1";"5.29";"2h";"CCCOc1cc(Cl)c(-c2c(C)nn3c(NCCNC4CCOCC4)cc(C)nc23)c(Cl)c1";"IC50";"'='";"207.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1771963";"Antagonist activity at NPY Y1 receptor in human SK-N-MC cells assessed as inhibition of NPY-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1770105";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307551";"";"";""
"CHEMBL516";"CYPROHEPTADINE";"4.0";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200709";"CROTAMITON";"4.0";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"MITOXANTRONE";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL44";"GENISTEIN";"2.0";"270.24";"0";"2.58";"genistein";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"Clotrimazole";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909078";"SODIUM ARSENITE";"None";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL419086";"";"None";"376.46";"1";"5.06";"1";"C[C@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL308130";"";"None";"422.53";"1";"6.93";"40g";"CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C(Cc1ccccc1)c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL113935";"";"None";"584.72";"2";"5.22";"2a (dihydropyridine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCCN2CCC(c3ccccc3)CC2)NC#N)c1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"14.14";"0.26";"3.05";"6.28";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL41392";"";"None";"472.59";"0";"2.32";"19";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCCc1ccccn1";"IC50";"'='";"11500.0";"nM";"4.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL707";"DOXAZOSIN";"4.0";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"METOPROLOL";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4.0";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1426722";"";"None";"403.51";"0";"4.59";"SID24800554";"Cc1ccc(-n2cc(CNCCn3nc(C)cc3C)c(-c3ccc(F)cc3)n2)cc1";"IC50";"'='";"10620.0";"nM";"4.97";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1707";"LOPERAMIDE HYDROCHLORIDE";"4.0";"513.51";"1";"5.09";"SID11533030";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3190644";"";"None";"295.34";"0";"3.71";"SID14727976";"CC(C)COC(=O)c1cccc2c1-c1ccccc1/C2=N\O";"IC50";"'='";"6459.0";"nM";"5.19";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1310577";"";"None";"329.90";"1";"5.05";"SID22411938";"CN(C)Cc1ccccc1Sc1cccc2ccccc12.Cl";"IC50";"'='";"6031.0";"nM";"5.22";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL788";"IDOXURIDINE";"4.0";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1214185";"ROXITHROMYCIN";"4.0";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL288355";"";"None";"487.60";"0";"2.94";"10 (RS)";"CC(NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccc(O)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"15.84";"0.29";"4.78";"5.41";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"None";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1095699";"AZASERINE";"2.0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL498847";"SECNIDAZOLE";"4.0";"185.18";"0";"0.48";"SECNIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL137";"METRONIDAZOLE";"4.0";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"MPA";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1148";"TORSEMIDE";"4.0";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL47244";"PICROTOXININ";"None";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1162";"NORETHINDRONE";"4.0";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909067";"";"None";"None";"None";"None";"MC 258714";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1306";"TERCONAZOLE";"4.0";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL20883";"TEGAFUR";"4.0";"200.17";"0";"-0.02";"TEGAFUR";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1908847";"SPARTEINE";"4.0";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1278088";"";"None";"432.57";"0";"2.53";"17m";"Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1286334";"Displacement of [125I]peptide YY from NPY1 receptor in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1275331";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3307551";"";"";""
"CHEMBL159450";"";"None";"536.70";"1";"4.28";"2i";"O=[N+]([O-])c1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"8.99";"0.17";"0.54";"4.61";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL217692";"";"None";"1917.26";"None";"None";"26";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CN[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1597.0";"nM";"5.80";"";"";"UO_0000065";"3.02";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1493";"FLAVOXATE";"4.0";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL413965";"FELBINAC";"4.0";"212.25";"0";"2.98";"FELBINAC";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL185";"FLUOROURACIL";"4.0";"130.08";"0";"-0.80";"5-fluorouracil";"O=c1[nH]cc(F)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1566";"ACARBOSE";"4.0";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1255901";"HUPERZINE A";"2.0";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL166606";"";"None";"514.09";"1";"4.50";"4, FR-233118";"COc1ccc2c(c1)CC(NCC1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.57";"0.19";"0.42";"7.74";"0";"CHEMBL756253";"Compound was evaluated for the inhibitory activity against human Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135229";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL2367892";"TEICOPLANIN";"None";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"-1.0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"ACYCLOVIR";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL153062";"4-NONYLPHENOL";"None";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"None";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL584";"NELFINAVIR";"4.0";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"OMEPRAZOLE";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4.0";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"CLONIDINE";"Clc1cccc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1650";"CORTISONE ACETATE";"4.0";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1068";"OXCARBAZEPINE";"4.0";"252.27";"0";"2.64";"SID26747194";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL294199";"CAPSAICIN";"4.0";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL115";"INDINAVIR";"4.0";"613.80";"1";"2.87";"INV";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1117";"IDARUBICIN";"4.0";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL4795468";"";"None";"764.20";"2";"2.46";"64";"N/C(=N/C(=O)NCCNC(=O)CCCl)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.5888";"nM";"9.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL164971";"";"None";"535.75";"1";"4.62";"2c";"COc1ccc2c(c1)CC(CNCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"10.36";"0.20";"0.93";"7.86";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL422583";"";"None";"559.18";"2";"7.84";"2l";"CCc1sc(CCc2cc(OCC(C)(C)C)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"12.98";"0.26";"-0.58";"8.50";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL52282";"";"None";"543.13";"2";"7.35";"2n";"CCc1sc(CCc2cc(OC3CCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL167318";"";"None";"521.73";"1";"4.38";"2";"COc1ccc2c(c1)CC(NCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"9.05";"0.17";"0.34";"6.68";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL357995";"BOPINDOLOL";"2.0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"BUSPIRONE";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL278172";"BENZOCAINE";"4.0";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL437002";"";"None";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL234926";"ALLYL ALCOHOL";"None";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL508338";"THIMEROSAL";"4.0";"404.82";"None";"None";"THIMEROSAL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL18701";"RO-201724";"None";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL942";"BISACODYL";"4.0";"361.40";"0";"4.11";"SID487150";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL420";"GUANABENZ";"4.0";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42710";"EUGENOL";"0.5";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1328017";"";"None";"280.20";"0";"2.86";"SID24794002";"CNCc1cc(Cl)cc(OC)c1OC(C)C.Cl";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1525599";"";"None";"433.35";"0";"4.53";"SID24829750";"COc1ccccc1-n1c(-c2ccccc2)c[n+]2c1CCc1ccccc1-2.[Br-]";"IC50";"'='";"8772.0";"nM";"5.06";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL105";"MITOMYCIN";"4.0";"334.33";"0";"-1.65";"Mitomycin C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL980";"GUAIFENESIN";"4.0";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1208572";"SALINOMYCIN";"2.0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"KETOPROFEN";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL511";"PYRILAMINE";"4.0";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL964";"DISULFIRAM";"4.0";"296.55";"0";"3.62";"SID56422197";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL452";"CLONAZEPAM";"4.0";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4.0";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1517";"OXYTETRACYCLINE";"4.0";"460.44";"1";"-1.24";"OXYTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1554";"DACTINOMYCIN";"4.0";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL728";"PROCHLORPERAZINE";"4.0";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL19019";"NALTREXONE";"4.0";"341.41";"0";"1.53";"NALTREXONE";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL128";"SUMATRIPTAN";"4.0";"295.41";"0";"1.32";"Sumatriptan";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1766";"DESOXIMETASONE";"4.0";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL107";"COLCHICINE";"4.0";"399.44";"0";"2.87";"COLCHICINE";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL622";"ETODOLAC";"4.0";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200623";"ETHYLESTRENOL";"4.0";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL559987";"";"None";"358.44";"0";"2.52";"2i";"CCc1oc(CCc2cc(N3CCOCC3)cc(NC(C)=O)n2)nc1C";"IC50";"'='";"320000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL560182";"";"None";"398.43";"0";"3.54";"2j";"CCc1oc(CCc2cc(N3CCOCC3)cc(NCC(F)(F)F)n2)nc1C";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL560263";"";"None";"343.39";"0";"2.04";"4";"Cc1nc(OCc2cc(N3CCOCC3)cc(NCC#N)n2)oc1C";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1387309";"";"None";"328.76";"0";"4.74";"SID17409452";"O=C(Nc1ccccc1)OCc1cc(-c2ccccc2Cl)on1";"IC50";"'='";"9004.0";"nM";"5.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3197426";"";"None";"378.43";"0";"3.84";"SID17516081";"CCOc1ccc(Oc2c(/C=N/NC(C)=O)c(C)nn2-c2ccccc2)cc1";"IC50";"'='";"8902.0";"nM";"5.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3199632";"";"None";"370.41";"0";"2.33";"SID22404679";"COc1cc(/C=N/NC(N)=O)ccc1OCC(=O)Nc1ccc(C)c(C)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL48449";"CANTHARIDIN";"4.0";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"PINDOLOL";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909072";"PIPAMAZINE";"4.0";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"2.0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL270299";"BAY-11-7085";"None";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL499815";"ATRACTYLOSIDE";"None";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL78109";"";"None";"410.90";"1";"5.72";"44d";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL567495";"";"None";"418.43";"0";"3.87";"12b";"O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2ccncc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1037451";"Inhibition of human NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155978";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL43753";"";"None";"487.60";"1";"2.42";"11 (R)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](CO)c1ccccc1";"IC50";"'='";"22300.0";"nM";"4.65";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL108545";"METHYL SALICYLATE";"4.0";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL262221";"";"None";"1991.34";"None";"None";"10";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)C(c1ccccc1)c1ccccc1";"IC50";"'='";"447.0";"nM";"6.35";"";"";"UO_0000065";"3.19";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1514";"nM";"9.82";"";"";"UO_0000065";"15.92";"0.30";"7.15";"5.33";"0";"CHEMBL3750353";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1319576";"";"None";"286.44";"0";"4.42";"SID22401155";"Nc1c2c(nc3sc4c(c13)CCCC4)CCCCCC2";"IC50";"'='";"26740.0";"nM";"4.57";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1570844";"";"None";"441.49";"0";"4.85";"SID14742654";"COc1ccc(-c2[nH]nc3c2C(c2ccc(OC)c(OC)c2)N(c2ccccc2)C3=O)cc1";"IC50";"'='";"7799.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1327690";"";"None";"331.80";"0";"4.16";"SID4262635";"N#Cc1nc(COc2ccc(Cl)cc2)oc1N1CCCCCC1";"IC50";"'='";"6664.0";"nM";"5.18";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1428935";"";"None";"373.80";"0";"4.84";"SID17504309";"N#CC(C#N)=C1C=CC=CN1/C(=C\c1ccco1)C(=O)c1ccc(Cl)cc1";"IC50";"'='";"4079.0";"nM";"5.39";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1531745";"";"None";"437.95";"0";"4.73";"SID17512984";"COc1cccc(-c2ccc(C#N)c(SCC(=O)NCCc3ccc(Cl)cc3)n2)c1";"IC50";"'='";"4576.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1335124";"";"None";"391.85";"1";"5.20";"SID17516454";"O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1ccccc1-c1ccccc1";"IC50";"'='";"6127.0";"nM";"5.21";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1534058";"";"None";"330.48";"0";"3.68";"SID14732377";"Cc1cccc(NC(S)=NN=C(S)NCc2ccccc2)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1568243";"";"None";"259.31";"0";"4.13";"SID17432603";"O=C(/C=C/c1cccc2ccccc12)c1ccncc1";"IC50";"'='";"5470.0";"nM";"5.26";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1599610";"";"None";"282.73";"0";"4.11";"SID17406965";"O=C(/C=C/c1cccc(Cl)c1)c1nc2ccccc2[nH]1";"IC50";"'='";"7697.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1573504";"";"None";"404.30";"0";"3.95";"SID857411";"Cl.N=c1n(Cc2ccc(Cl)cc2)c2ccccc2n1CC(O)c1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427504";"";"None";"402.35";"1";"6.53";"SID17433913";"O=C(CSCc1c(Cl)cccc1Cl)Nc1ccccc1-c1ccccc1";"IC50";"'='";"5687.0";"nM";"5.25";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1483730";"";"None";"452.35";"1";"5.05";"SID22404402";"Cc1ccc(OCCCCN(C)Cc2ccccc2)c(Br)c1.O=C(O)C(=O)O";"IC50";"'='";"8329.0";"nM";"5.08";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3214137";"";"None";"387.72";"1";"5.03";"SID17508441";"O=C(CSCc1ccc(Cl)cc1)N/N=C/c1c(Cl)cccc1Cl";"IC50";"'='";"8303.0";"nM";"5.08";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1509886";"";"None";"349.19";"1";"5.24";"SID17512715";"Cc1nc2ccc(F)cc2cc1C(=O)Nc1ccc(Cl)c(Cl)c1";"IC50";"'='";"8843.0";"nM";"5.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"1a; BIBP3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"10.23";"nM";"7.99";"";"";"UO_0000065";"16.87";"0.31";"5.61";"5.59";"0";"CHEMBL3750353";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3208997";"";"None";"322.37";"0";"3.06";"SID14739316";"COc1cc(/C=N/n2cnnc2)ccc1OCc1ccc(C)cc1";"IC50";"'='";"7083.0";"nM";"5.15";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1311646";"";"None";"394.52";"0";"4.49";"SID17412952";"CC(/C=C1\SC(=S)N(NC(=O)c2ccc(C)cc2)C1=O)=C\c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1431004";"";"None";"389.31";"0";"3.81";"SID14729548";"CCOc1nc(SCCOc2ccc(Cl)cc2Cl)nc(N(C)C)n1";"IC50";"'='";"5537.0";"nM";"5.26";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL37858";"SARAFLOXACIN";"-1.0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1440";"TETRACYCLINE";"4.0";"444.44";"1";"-0.21";"TETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201216";"DAPIPRAZOLE";"4.0";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"PRAZOSIN";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL698";"TETRACAINE";"4.0";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL269503";"";"None";"4241.70";"None";"None";"1";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"'='";"0.02";"nM";"10.70";"";"";"UO_0000065";"2.52";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL433627";"";"None";"471.61";"0";"3.23";"9 (S)";"C[C@H](NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL43627";"";"None";"532.09";"1";"4.19";"26";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)N1CCCc2ccccc2C1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL6273";"FLEROXACIN";"2.0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1512";"FLUNISOLIDE";"4.0";"434.50";"0";"2.27";"FLUNISOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL432237";"";"None";"565.72";"1";"4.73";"2b (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(N/C(=N/CCCN2CCC(C(C)(C)C)CC2)NC#N)c1";"IC50";"'='";"231.0";"nM";"6.64";"";"";"UO_0000065";"11.73";"0.22";"1.91";"4.92";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL1042";"CHOLECALCIFEROL";"4.0";"384.65";"1";"7.62";"CHOLECALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL559593";"";"None";"358.49";"0";"3.38";"2c";"CCCNc1cc(N2CCOCC2)cc(CCc2nc(C)c(CC)o2)n1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL549699";"";"None";"372.50";"0";"2.50";"3c";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)n(C)c1C";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL47";"ALPHA-TOCOPHEROL";"None";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2314836";"";"None";"1607.88";"None";"None";"BVD15-DO3A";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)CC1)C(=O)O";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"4.98";"None";"None";"None";"0";"CHEMBL2320849";"Displacement of [125I]-NPY from Y1 receptor in human MCF7 cells in presence of 1 uM BBN";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311470";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308403";"";"";""
"CHEMBL5314360";"ACONITINE";"-1.0";"645.75";"2";"0.65";"Aconitine";"CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"None";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL648";"CYCLIZINE";"4.0";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL773";"GLYCINE";"4.0";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL382204";"";"None";"539.10";"1";"4.91";"1q";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3C[C@H]3CCN(C)C[C@@H]3F)C2=O)CC1";"IC50";"'='";"436.52";"nM";"6.36";"";"";"UO_0000065";"11.80";"0.23";"1.45";"15.53";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL204050";"";"None";"506.09";"2";"6.10";"1k-2";"CC1CCN([C@@H]2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CC3CCNCC3)C2=O)CC1";"IC50";"'='";"97.72";"nM";"7.01";"";"";"UO_0000065";"13.85";"0.27";"0.91";"15.08";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL206799";"";"None";"521.11";"2";"5.15";"1g";"O=C1c2c(n(CCCN3CCCCC3)c3ccccc23)[C@H](Oc2ccc(Cl)cc2)CC1N1CCNCC1";"IC50";"'='";"331.13";"nM";"6.48";"";"";"UO_0000065";"12.43";"0.24";"1.33";"13.03";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL206671";"";"None";"534.14";"2";"6.98";"1f";"CC1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CCCN3CCCCC3)C2=O)CC1";"IC50";"'='";"645.65";"nM";"6.19";"";"";"UO_0000065";"11.59";"0.22";"-0.79";"16.41";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"AM";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3";"NICOTINE";"4.0";"162.24";"0";"1.85";"NICOTINE";"CN1CCC[C@H]1c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1386";"TRANSPLATIN";"3.0";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1210154";"";"None";"336.42";"1";"5.39";"10i";"C/C(=N\OC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1212488";"Displacement of [125I]peptide YY from human recombinant Y1 receptor expressed in SK-NM- cell";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208724";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1836315";"";"None";"489.69";"0";"4.14";"13";"Cn1cnc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc4c(s3)CCSc3ccccc3-4)CC2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1837821";"Antagonist activity at human NPY1 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL490427";"";"None";"400.44";"0";"4.64";"2r";"Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981716";"Inhibition of NPYY1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144170";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL77675";"";"None";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL338790";"";"None";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL660";"AMANTADINE";"4.0";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL376180";"AMINOPTERIN";"2.0";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"None";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL189036";"";"None";"653.71";"2";"5.22";"3d";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3C(F)(F)F)CC2)NC#N)c1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"12.01";"0.23";"2.63";"5.47";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL83255";"";"None";"373.50";"0";"4.11";"16";"CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750758";"In vitro binding affinity against rat neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1771259";"";"None";"464.40";"0";"4.51";"2f, CP-671906";"COc1cc(Cl)c(-c2c(C)nn3c(NCCNC4CCOCC4)cc(C)nc23)c(Cl)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1771963";"Antagonist activity at NPY Y1 receptor in human SK-N-MC cells assessed as inhibition of NPY-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1770105";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307551";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"1a; BIBP3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"17.74";"0.33";"6.02";"5.88";"0";"CHEMBL3750540";"Displacement of (R)-Na-Diphenylacetyl-Nomega[2-([2,3-3H]-propionylamino)ethyl]aminocarbonyl (4-hydroxybenzyl)-argininamide from NPY1R in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307551";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.3236";"nM";"9.49";"";"";"UO_0000065";"15.41";"0.29";"7.24";"5.07";"0";"CHEMBL3750540";"Displacement of (R)-Na-Diphenylacetyl-Nomega[2-([2,3-3H]-propionylamino)ethyl]aminocarbonyl (4-hydroxybenzyl)-argininamide from NPY1R in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307551";"";"";""
"CHEMBL1403281";"ERGOCRYPTINE";"None";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL13378";"(R,S)-AMPA";"None";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL116502";"";"None";"584.79";"1";"4.78";"2e (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(N/C(S)=N/CCCN2CCN(C3CCCCC3)CC2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL27769";"STANOLONE";"2.0";"290.45";"0";"3.96";"STANOLONE";"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1598608";"AZASETRON";"2.0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL440944";"";"None";"423.94";"0";"4.15";"1a";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3C)C2=O)CC1";"IC50";"'='";"25118.86";"nM";"4.60";"";"";"UO_0000065";"10.85";"0.21";"0.45";"12.20";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1342128";"";"None";"327.36";"0";"3.57";"SID4261856";"O=C(CSc1nc2ccccc2o1)c1ccc2c(c1)OCCO2";"IC50";"'='";"11350.0";"nM";"4.95";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3213775";"";"None";"334.38";"0";"2.07";"SID22401930";"CCCCC(=O)N/N=C/c1ccc(N2CCOCC2)c([N+](=O)[O-])c1";"IC50";"'='";"26730.0";"nM";"4.57";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1077";"BROMFENAC";"4.0";"334.17";"0";"2.89";"BROMFENAC";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046858";"";"None";"347.51";"0";"3.96";"9";"C[C@@H]1C[C@@H]2[C@H](C1)[C@@]2(c1cccc(N)c1)N1CCN(c2ccccc2)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"19.34";"0.35";"2.76";"20.68";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL415176";"";"None";"1700.97";"None";"None";"Ac-25-36[Cha30]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C1CCCCC1";"IC50";"'='";"44000.0";"nM";"4.36";"";"";"UO_0000065";"2.56";"None";"None";"None";"0";"CHEMBL750757";"Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"CHEMBL3307551";"";"";""
"CHEMBL1200693";"MANGANESE CHLORIDE ANHYDROUS";"4.0";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL203266";"TRIMETAZIDINE";"4.0";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1087";"MEPIVACAINE";"4.0";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL414357";"EXENATIDE";"4.0";"4186.64";"None";"None";"Ex-4";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1168";"RAMIPRIL";"4.0";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL413612";"";"None";"1915.24";"None";"None";"5";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"764.0";"nM";"6.12";"";"";"UO_0000065";"3.19";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL4743858";"";"None";"751.71";"2";"2.10";"57";"N/C(=N/C(=O)NCCNC(=O)C(F)F)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.1096";"nM";"9.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL1373";"MODAFINIL";"4.0";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"None";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL19299";"LOXOPROFEN";"4.0";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL932";"DIPYRIDAMOLE";"4.0";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL450895";"NYSTATIN";"4.0";"926.11";"3";"0.94";"NYSTATIN";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL509";"MECLOFENAMIC ACID";"4.0";"296.15";"0";"4.74";"MECLOFENAMIC ACID";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL178";"DAUNORUBICIN";"4.0";"527.53";"2";"1.03";"DAUNORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4.0";"376.50";"1";"5.12";"BETA-ESTRADIOL 3-BENZOATE";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL165506";"";"None";"507.70";"1";"4.13";"2m";"COc1ccc2c(c1)CC(NC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"35000.0";"nM";"4.46";"";"";"UO_0000065";"8.78";"0.17";"0.33";"6.31";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL90555";"VINCRISTINE";"4.0";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"NEVIRAPINE";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL114040";"";"None";"585.71";"1";"4.85";"2a (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(N/C(=N/CCCN2CCC(c3ccccc3)CC2)NC#N)c1";"IC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"11.22";"0.21";"1.72";"4.87";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL547";"ISOTRETINOIN";"4.0";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1660";"RIFAPENTINE";"4.0";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1612004";"";"None";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL14060";"PHENOL";"4.0";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"ROFECOXIB";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"OXAPROZIN";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL43882";"TRICHLOROETHANE";"None";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL273348";"TOSUFLOXACIN";"2.0";"404.35";"0";"2.04";"TOSUFLOXACIN";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1342624";"";"None";"460.41";"1";"5.52";"SID17401411";"Cc1cccc(OCCNC(=O)c2ccc(Oc3ccc(C(F)(F)F)cc3[N+](=O)[O-])cc2)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1482513";"";"None";"967.16";"3";"3.13";"SID24841414";"CC(=O)OC1COC(OC2C(O)C(C)OC(OC3C(OC4CCC5(C)C(CCC6(C)C5CC=C5C7CC(C)(C)CCC7(C(=O)O)CCC56C)C4(C)CO)OCC(O)C3O)C2O)C(O)C1OC(C)=O";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4.0";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL316561";"PROGLUMIDE";"4.0";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL822";"TERBINAFINE";"4.0";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL331578";"";"None";"568.72";"1";"4.21";"2g (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(NC(=O)NCCCN2CCN(C3CCCCC3)CC2)c1";"IC50";"'='";"434.0";"nM";"6.36";"";"";"UO_0000065";"11.19";"0.21";"2.15";"5.35";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL49177";"";"None";"607.22";"2";"8.43";"2t";"CCc1sc(CCc2cc(OCCCc3ccccc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4.0";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"MEDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL38737";"THIOACETAMIDE";"None";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"IC50";"'='";"0.2188";"nM";"9.66";"";"";"UO_0000065";"15.79";"0.29";"7.61";"5.12";"0";"CHEMBL3750353";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"Clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42625";"";"None";"497.64";"0";"3.62";"21";"N=C(N)NCCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2ccccc2C1";"IC50";"'='";"76000.0";"nM";"4.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL42793";"";"None";"499.62";"1";"3.08";"7 (RS)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NC1CCc2cc(O)ccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL425095";"";"None";"1849.18";"None";"None";"36";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"674.0";"nM";"6.17";"";"";"UO_0000065";"3.34";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL17645";"CGP-71683A";"None";"475.62";"0";"4.56";"8, (CGP-71683A)";"Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12";"IC50";"'='";"8370.0";"nM";"5.08";"";"";"UO_0000065";"10.68";"0.20";"0.52";"4.62";"0";"CHEMBL755161";"Compound was tested for human Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL77273";"";"None";"360.46";"1";"5.57";"40c";"C[C@H](Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL428915";"";"None";"563.12";"2";"6.40";"30";"CCN1CCCC1CNC(=O)c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@H]1F";"IC50";"'='";"263.0";"nM";"6.58";"";"";"UO_0000065";"11.68";"0.22";"0.18";"11.24";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL49177";"";"None";"607.22";"2";"8.43";"2t";"CCc1sc(CCc2cc(OCCCc3ccccc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.68";"0.25";"-0.73";"9.02";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL4751322";"";"None";"769.70";"2";"2.40";"58";"N/C(=N/C(=O)NCCNC(=O)C(F)(F)F)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.1259";"nM";"9.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4746035";"";"None";"733.72";"2";"1.81";"56";"N/C(=N/C(=O)NCCNC(=O)CF)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.05495";"nM";"10.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"None";"183.32";"None";"None";"CADMIUM CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"None";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL240208";"";"None";"537.08";"2";"5.82";"29";"CN(C)CCN(C)C(=O)c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@H]1F";"IC50";"'='";"191.0";"nM";"6.72";"";"";"UO_0000065";"12.51";"0.24";"0.90";"13.51";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL392583";"";"None";"558.06";"2";"6.04";"24";"O=C(c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@@H]1F)N1CCn2ccnc2C1";"IC50";"'='";"1905.0";"nM";"5.72";"";"";"UO_0000065";"10.25";"0.20";"-0.32";"8.89";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL239775";"";"None";"558.06";"2";"6.11";"23";"O=C(c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@@H]1F)N1CCc2[nH]cnc2C1";"IC50";"'='";"2882.0";"nM";"5.54";"";"";"UO_0000065";"9.93";"0.19";"-0.57";"7.37";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL526";"PROPOFOL";"4.0";"178.27";"0";"3.64";"72";"CC(C)c1cccc(C(C)C)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1341841";"";"None";"457.56";"0";"4.60";"SID14742039";"Cc1ccc(-c2nn3c(C)nnc3c3ccccc23)cc1S(=O)(=O)NC(C)c1ccccc1";"IC50";"'='";"20260.0";"nM";"4.69";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1379143";"";"None";"422.60";"0";"4.85";"SID17507889";"Cc1cccc(N=C(S)N(CCN(C)C)Cc2cc3cc(C)cc(C)c3nc2O)c1";"IC50";"'='";"6324.0";"nM";"5.20";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1419096";"";"None";"392.38";"0";"2.09";"SID4254597";"COC(=O)c1ccccc1NC(=O)Cn1c(-c2nonc2N)nc2ccccc21";"IC50";"'='";"4826.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1990096";"";"None";"325.41";"0";"4.67";"SID17387203";"C/C(=N\OC(=O)c1ccc(OC(C)C)cc1)c1ccc(C)c(C)c1";"IC50";"'='";"7084.0";"nM";"5.15";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL95764";"GLYPHOSATE";"None";"169.07";"0";"-1.20";"GLYPHOSATE";"O=C(O)CNCP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4.0";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1123";"DICYCLOMINE";"4.0";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL15511";"ENROFLOXACIN";"2.0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"None";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1568";"FLUDARABINE";"None";"285.24";"0";"-1.84";"FLUDARABINE";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909051";"";"None";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909057";"COPPER(II) OXIDE";"None";"79.55";"None";"None";"COPPER(II) OXIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"DIAZOXIDE";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"MIANSERIN";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL491288";"";"None";"375.38";"0";"3.31";"2a";"C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1022823";"Binding affinity to human neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138528";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL412698";"";"None";"2004.29";"None";"None";"18";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"3.29";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL17022";"";"None";"472.65";"1";"5.87";"7";"O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccc2ccccc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755162";"Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL40430";"";"None";"483.62";"0";"3.37";"6 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H]1CCc2ccccc21";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL41673";"";"None";"471.61";"0";"3.23";"8 (R)";"C[C@@H](NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL41673";"";"None";"471.61";"0";"3.23";"8 (R)";"C[C@@H](NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.47";"0.27";"3.59";"5.57";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL41981";"";"None";"487.60";"1";"2.42";"12 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](CO)c1ccccc1";"IC50";"'='";"184.0";"nM";"6.74";"";"";"UO_0000065";"13.81";"0.26";"4.32";"4.80";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL959";"RIMANTADINE";"4.0";"179.31";"0";"2.55";"Rimantadine";"CC(N)C12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200862";"METYROSINE";"4.0";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1555711";"";"None";"368.84";"0";"3.85";"SID17407295";"CCCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)O";"IC50";"'='";"16800.0";"nM";"4.78";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1328939";"";"None";"434.49";"1";"5.57";"SID24781483";"Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccccc3C(F)(F)F)sc2n1";"IC50";"'='";"7100.0";"nM";"5.15";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1556933";"";"None";"424.52";"0";"4.55";"SID24786009";"COc1ccc(N(C(=O)C2CCCCC2)S(=O)(=O)c2cccc3cccnc23)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1383077";"";"None";"388.53";"0";"4.14";"SID14732614";"CCC(C)(C(=O)NC1CCCC1)N(Cc1ccco1)C(=O)Cc1cccs1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"None";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"None";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"None";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046860";"";"None";"346.52";"0";"4.69";"11";"Cc1ccc([C@]2(N3CCN(c4ccccc4)CC3)[C@@H]3C[C@@H](C)C[C@@H]32)cc1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"18.29";"0.33";"1.65";"97.80";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL666";"FOSCARNET";"4.0";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL603";"ZAFIRLUKAST";"4.0";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1609320";"";"None";"422.98";"0";"3.84";"SID850003";"CC(C)CC(c1nnnn1C1CCCC1)N1CCN(c2ccccc2F)CC1.Cl";"IC50";"'<'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4753520";"";"None";"727.74";"2";"2.02";"63";"C=CC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.1862";"nM";"9.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL1219";"RABEPRAZOLE";"4.0";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"2.09";"None";"None";"None";"0";"CHEMBL1101404";"Inhibition of neuropeptide Y1 receptor in human SK-N-MC cells after 60 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153738";"1";"Scientific Literature";"J Nat Prod";"2009";"CHEMBL3307551";"";"";""
"CHEMBL567941";"";"None";"443.55";"0";"4.29";"2g";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3cccc(CF)n3)n2)oc1C";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"19.72";"0.39";"4.45";"11.46";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL17456";"";"None";"481.60";"0";"3.54";"3";"COc1cc2nc(N3CCC(N4C(=O)CC(C5CCCCC5)CC4=O)CC3)nc(N)c2cc1OC";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"10.49";"0.20";"1.51";"4.56";"0";"CHEMBL755162";"Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL567719";"";"None";"425.56";"0";"4.13";"2i";"Cc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc(C)c(C)o3)n2)n1";"IC50";"'='";"0.69";"nM";"9.16";"";"";"UO_0000065";"21.53";"0.42";"5.03";"12.01";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL566020";"";"None";"445.59";"0";"4.68";"3a";"Cc1nc(SCc2cc(N3CCSCC3)cc(NCc3cccc(F)n3)n2)oc1C";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"21.47";"0.44";"4.89";"14.26";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL470495";"";"None";"529.64";"1";"2.95";"8a";"CCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"2.239";"nM";"8.65";"";"";"UO_0000065";"16.33";"0.30";"5.70";"5.93";"0";"CHEMBL1011807";"Displacement of [3H]UR-MK114 from neuropeptide Y1 receptor in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151759";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307551";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"pNPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.9772";"nM";"9.01";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL1011807";"Displacement of [3H]UR-MK114 from neuropeptide Y1 receptor in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151759";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3307551";"";"";""
"CHEMBL1352348";"";"None";"369.49";"0";"4.14";"SID14745989";"Cc1cc(C(=O)CSc2nc3ccccc3[nH]2)c(C)n1CC1CCCO1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"PHENYLBUTAZONE";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3183075";"NIZATIDINE";"4.0";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1016";"CANDESARTAN";"3.0";"440.46";"0";"4.03";"CANDESARTAN";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1368744";"";"None";"309.35";"0";"3.76";"SID24816175";"Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL415644";"";"None";"1968.30";"None";"None";"14";"CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(C)C)[C@@H](C)O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL584908";"";"None";"429.52";"0";"3.96";"2c";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3ccnc(F)c3)n2)oc1C";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"19.29";"0.38";"4.32";"10.86";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1603366";"";"None";"314.41";"0";"3.93";"SID17432103";"Cc1ccc(NC(S)=NCc2ccc3c(c2)OCO3)cc1C";"IC50";"'='";"9957.0";"nM";"5.00";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1432676";"";"None";"341.93";"0";"4.73";"SID17403654";"CCN(CC)CC#CCC(C)(c1ccccc1)c1ccccc1.Cl";"IC50";"'<'";"12000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4.0";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL44618";"CHLOROFORM";"4.0";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"SID170464781";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL976";"PRAZIQUANTEL";"4.0";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL13209";"NITRAZEPAM";"4.0";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL116680";"";"None";"564.73";"2";"5.09";"2b (dihydropyridine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCCN2CCC(C(C)(C)C)CC2)NC#N)c1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL1730";"CEFOTAXIME";"4.0";"455.47";"1";"-0.62";"CTX";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"AMLODIPINE";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4.0";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL5314404";"AJMALINE";"3.0";"326.44";"0";"1.55";"AJMALINE";"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL441936";"";"None";"1917.26";"None";"None";"27";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CN[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)CC(C)C";"IC50";"'='";"769.0";"nM";"6.11";"";"";"UO_0000065";"3.19";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL116864";"";"None";"567.73";"1";"4.57";"2g (dihydropyridine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCCN2CCN(C3CCCCC3)CC2)c1";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"11.90";"0.22";"2.18";"5.84";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL65";"CAMPTOTHECIN";"-1.0";"348.36";"0";"2.08";"CAMPTOTHECIN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4.0";"613.91";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"FELODIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL562";"GRISEOFULVIN";"4.0";"352.77";"0";"2.81";"G";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1697694";"AFLATOXIN";"None";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL43523";"";"None";"500.60";"2";"1.91";"15 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](C(N)=O)c1ccccc1";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"PAPAVERINE";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42442";"OXFENDAZOLE";"2.0";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4.0";"172.62";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL117364";"";"None";"557.76";"2";"5.59";"2c (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(N/C(S)=N/CCCN2CCC(C(C)(C)C)CC2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL155553";"";"None";"477.63";"0";"3.51";"6f";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccs2)CC1)c1cc2ccccc2s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL566664";"";"None";"487.60";"0";"4.31";"2f";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3cccc(COCCF)n3)n2)oc1C";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.41";"0.32";"3.69";"9.35";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL567101";"";"None";"439.59";"0";"4.38";"2j";"CCc1oc(SCc2cc(N3CCOCC3)cc(NCc3cccc(C)n3)n2)nc1C";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"21.40";"0.41";"5.03";"12.33";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL567112";"";"None";"473.64";"1";"5.01";"2o";"CCc1sc(SCc2cc(N3CCOCC3)cc(NCc3cccc(C)n3)n2)nc1CF";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"20.87";"0.42";"4.88";"15.65";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1427745";"";"None";"405.50";"0";"3.51";"SID17512961";"CCC(NCCC(c1ccccc1)c1ccccc1)=C1C(=O)N(C)C(=O)N(C)C1=O";"IC50";"'='";"5265.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1545971";"";"None";"383.86";"0";"4.98";"SID847358";"Cc1onc(-c2ccccc2Cl)c1C(=O)Nc1sc2c(c1C#N)CCC2";"IC50";"'='";"7125.0";"nM";"5.15";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL268351";"";"None";"1727.01";"None";"None";"Ac-25-36[Cha30,Cha31]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C1CCCCC1)C1CCCCC1";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"2.65";"None";"None";"None";"0";"CHEMBL750757";"Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"CHEMBL3307551";"";"";""
"CHEMBL522589";"";"None";"400.44";"0";"4.64";"2s";"Cc1nc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)no1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981716";"Inhibition of NPYY1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144170";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL52325";"";"None";"557.16";"2";"7.60";"2k";"CCc1sc(CCc2cc(OCC3(C)CC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1909049";"";"None";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL289469";"GRANISETRON";"4.0";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL578";"ENALAPRIL";"4.0";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL222863";"OUABAIN";"4.0";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"FLUTAMIDE";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL188921";"BUFLOMEDIL";"4.0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1476898";"CADMIUM ACETATE";"None";"230.50";"None";"None";"CADMIUM ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL152016";"";"None";"500.44";"1";"3.06";"5b";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Br)cc2)CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL422583";"";"None";"559.18";"2";"7.84";"2l";"CCc1sc(CCc2cc(OCC(C)(C)C)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL77776";"";"None";"404.51";"1";"5.68";"44b";"Cc1ccc(Oc2ccc(NC(=O)N(C)[C@H](C)[C@@H](O)c3ccccc3)cc2)cc1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL298983";"";"None";"531.12";"2";"7.20";"2i";"CCc1sc(CCc2cc(OC(C)C)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.91";"0.30";"0.72";"9.28";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL415690";"BETADEX";"3.0";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"GUANETHIDINE";"N=C(N)NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1108";"DROPERIDOL";"4.0";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1405";"ESTRONE";"4.0";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL189171";"ACEMETACIN";"4.0";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL82374";"";"None";"417.55";"0";"4.72";"68";"CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750758";"In vitro binding affinity against rat neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1626";"CLEMASTINE";"4.0";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL177756";"FLUORESCEIN";"None";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL426123";"";"None";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2111764";"";"None";"2004.29";"None";"None";"19";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"47.9";"nM";"7.32";"";"";"UO_0000065";"3.65";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL456807";"PHENYLHYDRAZINE";"None";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"None";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1560529";"";"None";"520.63";"1";"5.26";"SID22415380";"COc1ccccc1OCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(O)C(=O)O";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585652";"";"None";"377.48";"0";"4.62";"SID17412688";"COc1ccccc1CCNCc1ccc(OC)c(OCc2ccccc2)c1";"IC50";"'='";"9050.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1350415";"";"None";"412.49";"1";"5.05";"SID17512721";"CC(C)OC(=O)/C(=C/c1ccc2c(c1)c1ccccc1n2C)NC(=O)c1ccccc1";"IC50";"'='";"19100.0";"nM";"4.72";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1391119";"";"None";"352.39";"0";"3.33";"SID17407403";"CCCCNC(=O)c1onc(CSc2ccccc2F)c1C(=O)O";"IC50";"'='";"14700.0";"nM";"4.83";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1311570";"";"None";"427.33";"1";"5.04";"SID862064";"Brc1ccc(CSc2nnc(-c3ccccn3)n2Cc2ccco2)cc1";"IC50";"'='";"7444.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL77769";"";"None";"376.46";"1";"5.06";"44i";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1cccc(Oc2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL3545252";"DOCETAXEL";"4.0";"861.94";"2";"3.26";"DOCETAXEL";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3350037";"";"None";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL635";"PREDNISONE";"4.0";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL182";"GANCICLOVIR";"4.0";"255.23";"0";"-1.97";"Ganciclovir";"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL382355";"";"None";"525.07";"1";"4.56";"1r";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3C[C@@H]3CCNC[C@@H]3F)C2=O)CC1";"IC50";"'='";"186.21";"nM";"6.73";"";"";"UO_0000065";"12.82";"0.25";"2.17";"13.53";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL379443";"";"None";"525.07";"1";"4.56";"1p";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3C[C@H]3CCNC[C@@H]3F)C2=O)CC1";"IC50";"'='";"239.88";"nM";"6.62";"";"";"UO_0000065";"12.61";"0.24";"2.06";"13.31";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL206723";"";"None";"507.08";"1";"4.62";"1i-2";"CN1CCN([C@@H]2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CC3CCNCC3)C2=O)CC1";"IC50";"'='";"776.25";"nM";"6.11";"";"";"UO_0000065";"12.05";"0.23";"1.49";"12.28";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL206112";"";"None";"436.98";"1";"6.27";"1c";"O=C1CC[C@@H](Oc2ccc(Cl)cc2)c2c1c1ccccc1n2CCCN1CCCCC1";"IC50";"'='";"7244.36";"nM";"5.14";"";"";"UO_0000065";"11.76";"0.23";"-1.13";"14.91";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"ACETAZOLAMIDE";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL712";"ANISINDIONE";"4.0";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4.0";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL557555";"CIPROFIBRATE";"4.0";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1398754";"";"None";"491.01";"1";"6.68";"SID17413392";"Cc1ccc(C)c(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3-c3ccccc3)ccc2Cl)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1393538";"";"None";"458.61";"0";"3.58";"SID14734196";"Cc1ccccc1C(=O)c1cccn1CC(=O)NCCN1CCN(c2cccc(C)c2C)CC1";"IC50";"'='";"6433.0";"nM";"5.19";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1462447";"";"None";"280.26";"0";"1.64";"SID14722665";"O=C(O)CSc1nnc(-c2ccc3c(c2)OCO3)o1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL127516";"BUTAMBEN";"4.0";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL926";"DOBUTAMINE";"4.0";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL545";"ALCOHOL";"4.0";"46.07";"0";"0.00";"ETHANOL";"CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL799";"CILOSTAZOL";"4.0";"369.47";"0";"3.46";"CILOSTAZOL";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL562831";"";"None";"402.50";"0";"2.54";"2h";"CCOC(=O)CNc1cc(N2CCOCC2)cc(CCc2nc(C)c(CC)o2)n1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1463";"FLUCYTOSINE";"4.0";"129.09";"0";"-0.51";"5-FC";"Nc1nc(=O)[nH]cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL19215";"METERGOLINE";"4.0";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL265766";"";"None";"607.78";"2";"5.72";"2d (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(N/C(S)=N/CCCN2CCC(c3cccc(OC)c3)CC2)c1";"IC50";"'='";"945.0";"nM";"6.03";"";"";"UO_0000065";"9.91";"0.19";"0.30";"5.57";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL269267";"";"None";"1931.24";"None";"None";"4";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1630578";"TIRILAZAD";"3.0";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL404811";"DIGITONIN";"None";"1229.32";"None";"None";"DIGITONIN";"C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"DIPHENHYDRAMINE";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"DOMPERIDONE";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL702";"PIPERACILLIN";"4.0";"517.56";"1";"-0.24";"Piperacillin";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL515";"CHLORAMBUCIL";"4.0";"304.22";"0";"3.38";"CHLORAMBUCIL";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"35";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL34139";"GENACONAZOLE";"None";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL808";"ECONAZOLE";"4.0";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL679";"EPINEPHRINE";"4.0";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL497359";"";"None";"387.36";"0";"4.25";"5k";"O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001158";"Binding affinity to NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL817";"TOLAZAMIDE";"4.0";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL109";"VALPROIC ACID";"4.0";"144.21";"0";"2.29";"VALPROIC ACID";"CCCC(CCC)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL239773";"";"None";"545.13";"2";"6.50";"20";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3CCCN2CCCCC2)CC1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.39";"0.26";"0.80";"17.83";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL508102";"CARBIMAZOLE";"4.0";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL541";"BENZOIC ACID";"4.0";"122.12";"0";"1.38";"BENZOIC ACID";"O=C(O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1399";"ANASTROZOLE";"4.0";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"AZITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL990";"BUTENAFINE";"4.0";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"SID90341257";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL441687";"GLYCYRRHIZIN";"2.0";"822.94";"3";"2.25";"GLYCYRRHIZIN";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL238517";"";"None";"549.09";"2";"5.92";"13";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3C[C@@H]2CCN(C)C[C@@H]2F)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"13.76";"0.26";"1.63";"18.44";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL240404";"";"None";"535.06";"2";"5.58";"12";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3C[C@@H]2CCNC[C@@H]2F)CC1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"13.63";"0.26";"1.71";"14.66";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"ASCORBIC ACID";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1308";"FOMEPIZOLE";"4.0";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL241694";"ETHISTERONE";"3.0";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL485259";"EUCALYPTOL";"3.0";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1256017";"ARCAINE SULFATE";"None";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"etoposide";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1480648";"";"None";"415.41";"0";"3.38";"SID4240898";"COc1ccc(-n2nc(C(=O)Nc3ccc4c(c3)OCO4)c3ccccc3c2=O)cc1";"IC50";"'='";"7156.0";"nM";"5.14";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493500";"";"None";"444.56";"1";"5.88";"SID22403379";"CCc1cccc(CC)c1NC(=O)COC(=O)c1ccccc1-c1nc2ccccc2s1";"IC50";"'='";"5769.0";"nM";"5.24";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1502859";"";"None";"375.43";"0";"2.14";"SID14743867";"O=c1c2ccccc2nc2c3ccccc3c(NCCN3CCOCC3)nn12";"IC50";"'='";"4380.0";"nM";"5.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386511";"";"None";"313.47";"0";"3.68";"SID17505233";"CN(C)CCCSc1nc(-c2ccccc2)nc2c1CCC2";"IC50";"'='";"7326.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3195229";"";"None";"399.24";"0";"4.39";"SID17510799";"O=C(N/N=C/c1ccco1)c1ccccc1OCc1ccc(Br)cc1";"IC50";"'='";"5335.0";"nM";"5.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1600727";"";"None";"357.49";"1";"5.21";"SID3716518";"c1ccc(-c2nc(CSc3nnc(-c4cccs4)o3)cs2)cc1";"IC50";"'='";"12770.0";"nM";"4.89";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1308845";"";"None";"458.74";"0";"4.97";"SID17414745";"Cc1cc(Cl)c(OCCCNCc2ccccc2)c(Br)c1.O=C(O)C(=O)O";"IC50";"'='";"5388.0";"nM";"5.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1563162";"";"None";"481.57";"0";"4.13";"SID848177";"O=C(CN(Cc1ccc2c(c1)OCO2)C(=O)CSc1nc2ccccc2o1)NC1CCCCC1";"IC50";"'='";"8583.0";"nM";"5.07";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1439255";"";"None";"327.80";"0";"3.65";"SID3715989";"Clc1ccc(-c2nnn(Cc3nc4ccccc4s3)n2)cc1";"IC50";"'='";"13400.0";"nM";"4.87";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1608982";"";"None";"341.43";"0";"4.16";"SID22413249";"Cc1ccc(S(=O)(=O)C(c2ccccc2)c2c(C)noc2C)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1453832";"";"None";"429.51";"0";"4.91";"SID14739446";"O=C(O)C(=O)O.c1ccc(COc2ccc(OCCCCN3CCCCC3)cc2)cc1";"IC50";"'='";"9458.0";"nM";"5.02";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1364371";"";"None";"389.47";"0";"4.31";"SID22413191";"CN1CCC(Oc2ccccc2Sc2ccccc2)CC1.O=C(O)C(=O)O";"IC50";"'='";"13610.0";"nM";"4.87";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1365319";"";"None";"246.31";"0";"2.48";"SID17509493";"CCCCOc1ccc(C2=NNC(=O)CC2)cc1";"IC50";"'='";"13630.0";"nM";"4.87";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1348426";"";"None";"399.96";"0";"3.62";"SID863911";"CC(C)COc1ccc(C(=O)OC2CC(C)(C)OCC2CN(C)C)cc1.Cl";"IC50";"'='";"5546.0";"nM";"5.26";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1308461";"";"None";"281.36";"0";"3.92";"SID863607";"Cc1nc(N2CCC(C)CC2)c2oc3ccccc3c2n1";"IC50";"'='";"7229.0";"nM";"5.14";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1389702";"";"None";"378.51";"0";"4.21";"SID17505574";"Cc1ccc(N=C(S)N=C(N)Nc2nc(C)c3cc(C)ccc3n2)c(C)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468490";"";"None";"331.80";"0";"2.65";"SID7967718";"O=C1C2CC=C(Cl)CC2C(=O)N1CC1Cc2ccccc2CO1";"IC50";"'='";"7817.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL5315124";"LEVOFLOXACIN";"4.0";"740.76";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1167";"SPECTINOMYCIN";"4.0";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL129";"ZIDOVUDINE";"4.0";"267.24";"0";"-0.20";"AZT";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1236282";"THIAMPHENICOL";"2.0";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2314835";"";"None";"3240.75";"None";"None";"t-BBN/BVD15-DO3A";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)[C@H](CCCCNC(=O)COCC(=O)NCCOCCOCC(=O)NCC(=O)Nc1ccc(C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)cc1)NC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"2.19";"None";"None";"None";"0";"CHEMBL2320849";"Displacement of [125I]-NPY from Y1 receptor in human MCF7 cells in presence of 1 uM BBN";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311470";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308403";"";"";""
"CHEMBL417711";"";"None";"526.47";"1";"4.19";"28";"N=C(N)NCCCC(NC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)NCc1ccccc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL276832";"HYDRALAZINE";"4.0";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL683";"CLOFIBRIC ACID";"2.0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1455";"ALTRETAMINE";"4.0";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL167911";"DICHLORVOS";"2.0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2397297";"";"None";"377.53";"0";"4.17";"16";"CCOc1cccc(C2(N3CCN(c4ccncc4)CC3)C3CC(C)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397291";"";"None";"378.52";"0";"3.57";"10";"CCOc1cccc(C2(N3CCN(c4ncccn4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"19.20";"0.35";"3.70";"17.52";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397201";"";"None";"377.53";"0";"4.17";"9";"CCOc1cccc(C2(N3CCN(c4ccccn4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"19.54";"0.36";"3.21";"25.79";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1614641";"FLUNOXAPROFEN";"2.0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL372795";"STREPTOMYCIN";"4.0";"581.58";"3";"-8.16";"streptomycin";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL160";"CYCLOSPORINE";"4.0";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL427594";"";"None";"2007.34";"None";"None";"35";"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"48.9";"nM";"7.31";"";"";"UO_0000065";"3.64";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL43628";"";"None";"458.57";"0";"2.28";"18";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccccn1";"IC50";"'='";"3750.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL296523";"";"None";"483.62";"0";"3.37";"5 (R)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H]1CCc2ccccc21";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL83668";"TOLNAFTATE";"4.0";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42686";"";"None";"500.60";"2";"1.91";"14 (R)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](C(N)=O)c1ccccc1";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL41981";"";"None";"487.60";"1";"2.42";"12 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](CO)c1ccccc1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL50184";"";"None";"558.15";"2";"6.25";"1";"CCc1sc(CCc2cc(N3CCOCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"15.86";"0.32";"2.60";"9.99";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL2046869";"";"None";"362.52";"0";"4.39";"7";"COc1ccccc1[C@]1(N2CCN(c3ccccc3)CC2)[C@@H]2C[C@@H](C)C[C@@H]21";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"16.24";"0.30";"1.50";"37.47";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL123292";"CYCLOHEXIMIDE";"2.0";"281.35";"0";"1.04";"CYCLOHEXIMIDE";"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"None";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2105807";"MADURAMICIN";"2.0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL891";"CLOXACILLIN";"4.0";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"1";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL888";"GEMCITABINE";"4.0";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"None";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL293492";"CINNAMALDEHYDE";"-1.0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL597";"PHENTOLAMINE";"4.0";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL414804";"OXALIPLATIN";"4.0";"395.27";"None";"None";"OXALIPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909068";"";"None";"None";"None";"None";"MC 258717";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1540";"PENCICLOVIR";"4.0";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL469912";"PUROMYCIN";"2.0";"471.52";"1";"-0.79";"PUROMYCIN";"COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200558";"BACITRACIN";"4.0";"1422.72";"None";"None";"BACITRACIN";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2.0";"330.47";"0";"3.84";"HYDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1351";"CARBOPLATIN";"4.0";"371.25";"None";"None";"CARBOPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1370561";"AMINOPHYLLINE";"4.0";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046861";"";"None";"348.49";"0";"4.09";"12";"C[C@@H]1C[C@@H]2[C@H](C1)[C@@]2(c1ccc(O)cc1)N1CCN(c2ccccc2)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"19.43";"0.36";"2.68";"25.34";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL1727";"CEPHALEXIN ANHYDROUS";"4.0";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL496";"HEXACHLOROPHENE";"4.0";"406.91";"1";"6.61";"SID8139957";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL469";"KETOROLAC";"4.0";"255.27";"0";"2.29";"KETOROLAC";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"Aztreonam";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL508271";"";"None";"353.81";"0";"3.88";"5i";"O=C1OC2(CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001158";"Binding affinity to NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4745338";"";"None";"741.77";"2";"2.25";"68";"N/C(=N/C(=O)NCCNC(=O)C1CC1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.2399";"nM";"9.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909050";"";"None";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL768";"ESMOLOL";"4.0";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1366";"AURANOFIN";"4.0";"678.49";"None";"None";"AURANOFIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"Cimetidine";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"ACEBUTOLOL";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL29292";"UBENIMEX";"2.0";"308.38";"0";"0.53";"UBENIMEX";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL141";"LAMIVUDINE";"4.0";"229.26";"0";"-0.59";"3TC";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"None";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL221886";"SISOMICIN";"3.0";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"irinotecan";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL295416";"PIRINIXIC ACID";"2.0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3.0";"76.10";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"None";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL960";"LEFLUNOMIDE";"4.0";"270.21";"0";"3.25";"LEFLUNOMIDE";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL856";"PRIMIDONE";"4.0";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201356";"METHYLERGONOVINE";"4.0";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046868";"";"None";"332.49";"0";"4.38";"6";"C[C@@H]1C[C@@H]2[C@H](C1)[C@@]2(c1ccccc1)N1CCN(c2ccccc2)CC1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"17.02";"0.31";"1.28";"87.31";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL2046862";"";"None";"362.52";"0";"4.39";"13";"COc1ccc([C@]2(N3CCN(c4ccccc4)CC3)[C@@H]3C[C@@H](C)C[C@@H]32)cc1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"17.27";"0.32";"1.87";"39.84";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL1909070";"NAFENOPIN";"2.0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL716";"QUETIAPINE";"4.0";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL204583";"";"None";"520.12";"2";"6.73";"1e";"O=C1c2c(n(CCCN3CCCCC3)c3ccccc23)[C@H](Oc2ccc(Cl)cc2)CC1N1CCCCC1";"IC50";"'='";"3388.44";"nM";"5.47";"";"";"UO_0000065";"10.52";"0.20";"-1.26";"14.51";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"ERYTHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL838";"BENAZEPRIL";"4.0";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL438";"SULFAMERAZINE";"4.0";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1475";"TRIOXSALEN";"4.0";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL238071";"VINDESINE";"4.0";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4.0";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"SILDENAFIL";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL211501";"ANTIMYCIN A";"None";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"ATROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1230813";"ALFADEX";"2.0";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4.0";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL430274";"";"None";"1921.27";"None";"None";"7";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccsc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"257.0";"nM";"6.59";"";"";"UO_0000065";"3.43";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"None";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"6";"COc1c2occc2cc2ccc(=O)oc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL184618";"FRAMYCETIN";"3.0";"614.65";"3";"-8.90";"NEOMYCIN";"NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL92401";"IPRONIAZID";"4.0";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4.0";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"NORFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"None";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"NITRENDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL672";"FENOFIBRATE";"4.0";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1984816";"";"None";"324.30";"0";"2.78";"SID24788030";"COc1ccc(C(=O)/C(C#N)=N/Nc2cccc([N+](=O)[O-])c2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL187620";"";"None";"615.74";"1";"4.21";"3f";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3OC)CC2)NC#N)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.64";"0.25";"4.19";"5.49";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL414482";"";"None";"1700.97";"None";"None";"Ac-25-36[Cha31]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C1CCCCC1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"4.36";"None";"None";"None";"0";"CHEMBL750757";"Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"CHEMBL3307551";"";"";""
"CHEMBL1753";"CLINDAMYCIN";"4.0";"424.99";"0";"0.39";"CLINDAMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1198";"PRAMOXINE";"4.0";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL103";"PROGESTERONE";"4.0";"314.47";"0";"4.72";"PROGESTERONE";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"None";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL188271";"";"None";"561.68";"1";"4.49";"6a";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3)CC2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.49";"0.29";"4.21";"6.99";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL1457690";"";"None";"467.79";"1";"5.18";"SID24826569";"COc1ccc(-[n+]2c(-c3ccc(Cl)cc3)cn3c2CCc2ccccc2-3)cc1.[Br-]";"IC50";"'='";"7359.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1419672";"";"None";"493.63";"0";"3.77";"SID17416335";"COc1ccc([N+](=O)[O-])cc1N(CC(O)CN(CC(C)C)CC(C)C)S(=O)(=O)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1421312";"";"None";"353.43";"0";"3.21";"SID24798532";"COc1ccc(-c2noc(CN3CCCCC3c3nccn3C)n2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1501390";"";"None";"298.30";"0";"3.29";"SID862846";"COc1cccc(Oc2c[nH]nc2-c2ccc(O)cc2O)c1";"IC50";"'<'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1376342";"";"None";"289.33";"0";"4.85";"SID14727415";"O=C(O)c1ccc(N(c2ccccc2)c2ccccc2)cc1";"IC50";"'='";"31850.0";"nM";"4.50";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377690";"";"None";"437.78";"1";"6.39";"SID24828806";"Clc1ccc(-c2csc(Nc3ccccc3)[n+]2Cc2ccco2)c(Cl)c1.[Cl-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL530291";"";"None";"339.32";"0";"3.53";"SID857902";"Br.CCCCCCn1c2c(c(=N)c3c1CCC3)CCC2";"IC50";"'='";"8751.0";"nM";"5.06";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3198593";"";"None";"377.83";"0";"3.91";"SID14729910";"CCOC(=O)C(/C=N/c1cc(C)nn1-c1ccc(Cl)cc1)=C(\O)OCC";"IC50";"'='";"18920.0";"nM";"4.72";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1533962";"";"None";"402.56";"0";"4.53";"SID14737824";"CCC(C)(C(=O)NC1CCCCC1)N(Cc1ccco1)C(=O)Cc1cccs1";"IC50";"'='";"12260.0";"nM";"4.91";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1544103";"";"None";"402.36";"0";"3.81";"SID24830338";"CC1(C)CC(N2CCCCCC2)=CC(=[N+]2CCCC2)C1.[I-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1371937";"PANTHENOL";"3.0";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2314835";"";"None";"3240.75";"None";"None";"t-BBN/BVD15-DO3A";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)[C@H](CCCCNC(=O)COCC(=O)NCCOCCOCC(=O)NCC(=O)Nc1ccc(C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)cc1)NC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"2.20";"None";"None";"None";"0";"CHEMBL2320848";"Binding affinity to Y1 receptor in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311470";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4.0";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1566956";"TROXIPIDE";"2.0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"5b";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42747";"";"None";"513.64";"1";"3.25";"4";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCCc2cc(O)ccc2C1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"12.02";"0.22";"2.92";"4.69";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1200656";"NATAMYCIN";"4.0";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4.0";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL424";"SALICYLIC ACID";"4.0";"138.12";"0";"1.09";"Saver";"O=C(O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL51422";"";"None";"573.20";"2";"8.38";"2f";"CCCCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"12.56";"0.25";"-1.18";"8.43";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1349";"VALACYCLOVIR";"4.0";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL240221";"";"None";"479.98";"1";"5.89";"32";"CN(C)C(=O)c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@H]1F";"IC50";"'='";"12022.0";"nM";"4.92";"";"";"UO_0000065";"10.25";"0.20";"-0.97";"10.58";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL434";"ISOPROTERENOL";"4.0";"211.26";"0";"1.13";"ISOPRENALINE";"CC(C)NCC(O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1393";"SPIRONOLACTONE";"4.0";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1221";"SULCONAZOLE";"4.0";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4.0";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL445206";"ISOEUGENOL";"None";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"ITRACONAZOLE";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1360997";"";"None";"440.59";"0";"3.54";"SID14722452";"CCN(CC)S(=O)(=O)c1ccc(Oc2ccc(S(=O)(=O)N(CC)CC)cc2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL424862";"";"None";"521.11";"1";"4.96";"1o";"CN1CCC(Cn2c3c(c4ccccc42)C(=O)C(N2CCN(C)CC2)C[C@H]3Oc2ccc(Cl)cc2)CC1";"IC50";"'='";"33.88";"nM";"7.47";"";"";"UO_0000065";"14.33";"0.28";"2.51";"18.24";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1231530";"BETAMIPRON";"2.0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046863";"";"None";"350.48";"0";"4.52";"14";"C[C@@H]1C[C@@H]2[C@H](C1)[C@@]2(c1ccc(F)cc1)N1CCN(c2ccccc2)CC1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"19.24";"0.35";"2.22";"104.09";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1202";"nM";"9.92";"";"";"UO_0000065";"18.21";"0.34";"7.18";"6.28";"0";"CHEMBL3750352";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 5 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1622";"nM";"9.79";"";"";"UO_0000065";"15.87";"0.30";"7.12";"5.31";"0";"CHEMBL3750352";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 5 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.21";"0.30";"7.33";"5.43";"0";"CHEMBL3750355";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 20 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1836103";"";"None";"529.75";"2";"5.72";"11";"COc1ccc(C)cc1S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837821";"Antagonist activity at human NPY1 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL45245";"";"None";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"AMITRIPTYLINE";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL710";"FINASTERIDE";"4.0";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1243";"SULFABENZAMIDE";"4.0";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL187490";"";"None";"620.15";"1";"4.86";"3i";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3cccc(Cl)c3)CC2)NC#N)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.06";"0.25";"3.24";"5.64";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL360188";"";"None";"596.13";"2";"5.14";"6i";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3cccc(Cl)c3)CC2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.58";"0.26";"2.96";"6.50";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL177";"AMIKACIN";"4.0";"585.61";"3";"-8.42";"AMIKACIN";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"-1.0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1425";"MERCAPTOPURINE ANHYDROUS";"4.0";"152.18";"0";"0.64";"6-MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL25719";"GERANIOL";"None";"154.25";"0";"2.67";"GERANIOL";"CC(C)=CCC/C(C)=C/CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1371125";"BENZO[E]PYRENE";"None";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL45869";"";"None";"579.17";"2";"8.00";"2r";"CCc1sc(CCc2cc(OCc3ccccc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"237.0";"nM";"6.62";"";"";"UO_0000065";"11.44";"0.23";"-1.37";"7.76";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL187782";"";"None";"669.71";"2";"5.10";"3g";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3OC(F)(F)F)CC2)NC#N)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"11.28";"0.21";"2.45";"4.94";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL187492";"";"None";"629.68";"2";"5.51";"6d";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3C(F)(F)F)CC2)c1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"11.92";"0.23";"2.00";"6.03";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL187555";"";"None";"591.71";"1";"4.50";"6f";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3OC)CC2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.70";"0.28";"4.20";"6.50";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL362083";"";"None";"607.78";"2";"5.21";"6j";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3SC)CC2)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.66";"0.26";"3.09";"6.67";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL438923";"";"None";"1917.26";"None";"None";"28";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CN[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)CC(C)C";"IC50";"'='";"1390.0";"nM";"5.86";"";"";"UO_0000065";"3.05";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"1a; BIBP3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"11.75";"nM";"7.93";"";"";"UO_0000065";"16.74";"0.31";"5.55";"5.55";"0";"CHEMBL3750349";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 secs by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL559147";"Y-27632";"None";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL415324";"TRANILAST";"3.0";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1610409";"";"None";"328.82";"1";"5.19";"SID17409825";"Clc1ccccc1CSc1nnc(/C=C/c2ccccc2)o1";"IC50";"'='";"6959.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1973629";"";"None";"355.46";"0";"3.60";"SID14732975";"CCCCCCCCCS(=O)(=O)N/N=C/c1cccc([N+](=O)[O-])c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1471779";"";"None";"500.53";"2";"5.11";"SID17514496";"COC(=O)c1c(C)oc2ccc(N(C(=O)c3ccncc3)S(=O)(=O)c3ccc4ccccc4c3)cc12";"IC50";"'='";"4838.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL757";"NANDROLONE";"3.0";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL117405";"";"None";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL504760";"CAMPHOR";"4.0";"152.24";"0";"2.40";"D-CAMPHOR";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1458887";"";"None";"362.74";"0";"4.66";"SID24796859";"CC(C)(C)NCc1cc(Br)ccc1OC1CCCC1.Cl";"IC50";"'='";"7428.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1439337";"";"None";"469.51";"1";"5.83";"SID14726077";"CC(C)(C)n1nnnc1C(c1ccc(C(F)(F)F)cc1)N(Cc1ccccc1)Cc1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1462215";"";"None";"492.45";"1";"5.49";"SID24785323";"CC[n+]1c(/C=C2\SC(c3ccccc3C)=CN2C)sc2ccccc21.[I-]";"IC50";"'='";"6978.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1504083";"";"None";"375.58";"0";"4.55";"SID24800562";"CCOC(=O)C1(CCCc2ccccc2)CCN(C2CCSCC2)CC1";"IC50";"'='";"16710.0";"nM";"4.78";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1337101";"";"None";"356.47";"0";"2.38";"SID24826951";"CC(NC(=O)Cn1c(NCCO)nc2ccccc21)C1CC2CCC1C2";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468579";"";"None";"312.33";"0";"3.60";"SID865285";"COc1ccc(Oc2c(C)n[nH]c2-c2ccc(O)cc2O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312220";"";"None";"351.43";"0";"4.14";"SID24807484";"Cc1cc2cc(C)c(NCCNC(=O)c3cccc(F)c3)nc2cc1C";"IC50";"'='";"3391.0";"nM";"5.47";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1531251";"";"None";"515.06";"0";"3.73";"SID842834";"COc1ccc(N2CCN(C(c3cccc(OC)c3OC)c3nnnn3C3CCCC3)CC2)cc1.Cl";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1545811";"";"None";"410.52";"0";"3.86";"SID14737860";"O=C(c1cnccn1)N(Cc1ccco1)C1(C(=O)NC2CCCCC2)CCCCC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL483251";"";"None";"388.25";"0";"4.54";"5bb";"O=C1OC2(CCN(c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001158";"Binding affinity to NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL783";"NATEGLINIDE";"4.0";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"1.445";"nM";"8.84";"";"";"UO_0000065";"14.33";"0.27";"6.17";"4.80";"0";"CHEMBL3750349";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 secs by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4.0";"444.44";"1";"-0.35";"DOXYCYCLINE";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1515611";"BROMISOVALUM";"2.0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL267044";"LEVOSULPIRIDE";"2.0";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200604";"TROPICAMIDE";"4.0";"284.36";"0";"2.21";"TROPICAMIDE";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"TRIFLUOPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL471";"SOTALOL";"4.0";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4.0";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"-1.0";"341.83";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200845";"HALCINONIDE";"4.0";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4.0";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1343692";"";"None";"416.54";"0";"3.83";"SID24834434";"COc1ccc(N(C)S(=O)(=O)c2cccc(C(=O)NC3CCC(C)CC3)c2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386178";"";"None";"376.20";"0";"3.56";"SID858326";"CC(NC(=O)Nc1nnc(C(F)(F)F)s1)(C(F)(F)F)C(F)(F)F";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL70927";"DEFERIPRONE";"4.0";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046870";"";"None";"362.52";"0";"4.39";"8";"COc1cccc([C@]2(N3CCN(c4ccccc4)CC3)[C@@H]3C[C@@H](C)C[C@@H]32)c1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"17.99";"0.33";"2.13";"41.52";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"neuropeptide Y";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"2.26";"None";"None";"None";"0";"CHEMBL2395094";"Displacement of [125I]Peptide YY from neuropeptide Y receptor type 1 in human SK-N-MC cells after 60 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL1196";"PROPARACAINE";"4.0";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL115769";"";"None";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL462547";"URETHANE";"4.0";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"IC50";"'='";"4.266";"nM";"8.37";"";"";"UO_0000065";"13.68";"0.25";"6.32";"4.44";"0";"CHEMBL3750349";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 secs by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.4786";"nM";"9.32";"";"";"UO_0000065";"17.11";"0.32";"6.58";"5.90";"0";"CHEMBL3750350";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 1 min by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.4266";"nM";"9.37";"";"";"UO_0000065";"15.55";"0.29";"7.09";"5.09";"0";"CHEMBL3750351";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 2 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1047";"nM";"9.98";"";"";"UO_0000065";"16.18";"0.30";"7.31";"5.42";"0";"CHEMBL3750354";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 15 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1538792";"";"None";"440.57";"0";"4.19";"SID24819695";"CCOC(=O)c1c(CSc2ccccc2)n(C)c2ccc(O)c(CN3CCOCC3)c12";"IC50";"'='";"1938.0";"nM";"5.71";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1359108";"";"None";"674.70";"2";"5.89";"SID24708168";"COC(=O)[C@@]1(Cc2ccc(F)cc2)[C@H]2c3cc(C(=O)N4CCCC4)n(Cc4ccc(C(F)(F)F)nc4)c3C[C@H]2CN1C(=O)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1608455";"";"None";"470.53";"0";"4.09";"SID845473";"COc1ccccc1CN(Cc1cc2cc(C)ccc2nc1O)Cc1nnnn1Cc1ccco1";"IC50";"'='";"22650.0";"nM";"4.64";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1537";"AZLOCILLIN";"4.0";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL701";"BACLOFEN";"4.0";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"TRAZODONE";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL41166";"";"None";"457.58";"0";"2.96";"20";"N=C(N)NCCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)NCc1ccccc1";"IC50";"'='";"21800.0";"nM";"4.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL439638";"";"None";"455.99";"0";"2.95";"5c";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL54440";"MEVASTATIN";"2.0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SULFASALAZINE";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL78040";"";"None";"401.51";"1";"5.40";"47";"CCn1c2ccccc2c2cc(NC(=O)N(C)[C@H](C)[C@@H](O)c3ccccc3)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL423192";"ANISOMYCIN";"None";"265.31";"0";"0.50";"ANISOMYCIN";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"Ciprofloxacin";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1385840";"ERGOCORNINE";"None";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL56367";"NIMESULIDE";"4.0";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"None";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1471370";"";"None";"411.53";"0";"3.51";"SID24831665";"Cc1cc(C(=O)CSc2nc3ccccc3c(=O)n2C)c(C)n1CC1CCCO1";"IC50";"'<'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1392785";"";"None";"416.54";"0";"3.83";"SID24833623";"COc1ccc(N(C)S(=O)(=O)c2cccc(C(=O)NCC3CCCCC3)c2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1550015";"";"None";"390.46";"0";"3.19";"SID17407200";"Cc1ccc(C)c(SCc2noc(C(=O)NCC3CCCO3)c2C(=O)O)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1550184";"";"None";"416.39";"0";"3.92";"SID24829580";"CC1CC(C)CN(C2=CC(=[N+]3CCCC3)CC(C)(C)C2)C1.[I-]";"IC50";"'='";"15070.0";"nM";"4.82";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL48947";"";"None";"517.10";"2";"6.82";"2b";"CCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"14.47";"0.29";"0.66";"8.76";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL48897";"";"None";"593.19";"2";"8.04";"2s";"CCc1sc(CCc2cc(OCCc3ccccc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL446";"SULFAMETHAZINE";"4.0";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL404";"TAZOBACTAM";"4.0";"300.30";"0";"-1.52";"TAZOBACTAM";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1384";"KANAMYCIN";"4.0";"484.50";"2";"-7.29";"KANAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909062";"LEAD (II) ACETATE";"None";"325.29";"None";"None";"LEAD (II) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909065";"MADURAMICIN";"2.0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL491930";"";"None";"400.44";"0";"3.84";"5c";"O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1008338";"Inhibition of human NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136978";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL52108";"";"None";"573.16";"2";"6.97";"2q";"CCc1sc(CCc2cc(OC3CCOCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"14.58";"0.29";"1.39";"8.83";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL17450";"";"None";"473.59";"1";"7.10";"2";"CCCCN(CCCC)CCCNc1nc(Nc2cccc(C(F)(F)F)c2)c2ccccc2n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"12.67";"0.24";"-1.10";"11.30";"0";"CHEMBL755162";"Compound was tested for its affinity to bind with Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL351082";"";"None";"507.70";"1";"3.84";"2p";"COc1ccc2c(c1)CC(CNCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"9.17";"0.18";"0.82";"6.59";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL438935";"";"None";"2003.35";"None";"None";"17";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"762.0";"nM";"6.12";"";"";"UO_0000065";"3.05";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL599";"MELOXICAM";"4.0";"351.41";"0";"1.95";"MELOXICAM";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL412257";"";"None";"1990.31";"None";"None";"42";"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1567.0";"nM";"5.80";"";"";"UO_0000065";"2.92";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"Ketoconazole";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL564513";"";"None";"344.46";"0";"2.99";"2a";"CCNc1cc(N2CCOCC2)cc(CCc2nc(C)c(CC)o2)n1";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL316153";"";"None";"399.56";"0";"4.36";"70";"Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)C(C)C)CC3)sc1CCO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750758";"In vitro binding affinity against rat neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1307319";"";"None";"420.54";"0";"4.30";"SID847305";"CCN(C(=O)c1ccc(C(C)(C)C)cc1)c1nnc(Cn2nnc3ccccc32)s1";"IC50";"'='";"3205.0";"nM";"5.49";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1562842";"";"None";"412.53";"0";"4.60";"SID24797338";"COc1ccccc1N(CC(=O)NC1CCCC1)C(=O)c1oc(C(C)(C)C)cc1C";"IC50";"'='";"30390.0";"nM";"4.52";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"2.27";"None";"None";"None";"0";"CHEMBL3876375";"Displacement of [125I]peptide YY from Y1 receptor in human SK-N-MC cells measured after 120 mins by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875185";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3307551";"";"";""
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"VALDECOXIB";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL189";"MILRINONE";"4.0";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"VALSARTAN";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42747";"";"None";"513.64";"1";"3.25";"4";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCCc2cc(O)ccc2C1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL41457";"";"None";"492.02";"0";"3.54";"25";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)NCc1ccccc1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.05012";"nM";"10.30";"";"";"UO_0000065";"17.09";"0.32";"8.02";"5.59";"0";"CHEMBL3750355";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 20 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.5129";"nM";"9.29";"";"";"UO_0000065";"15.06";"0.28";"6.62";"5.04";"0";"CHEMBL3750350";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 1 min by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.0631";"nM";"10.20";"";"";"UO_0000065";"16.92";"0.32";"7.92";"5.54";"0";"CHEMBL3750354";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 15 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL566663";"";"None";"455.58";"0";"3.97";"2e";"COCc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc(C)c(C)o3)n2)n1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"18.36";"0.36";"4.40";"9.78";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL51284";"";"None";"559.18";"2";"7.98";"2m";"CCc1sc(CCc2cc(OC(CC)CC)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"14.77";"0.30";"0.28";"9.68";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL188790";"";"None";"585.71";"1";"4.20";"3a";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3)CC2)NC#N)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.66";"0.25";"3.80";"5.57";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL567708";"";"None";"429.52";"0";"3.96";"2b";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3cccnc3F)n2)oc1C";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"18.89";"0.37";"4.15";"10.63";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL158344";"";"None";"485.63";"0";"3.76";"6d";"Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cc4ccccc4s3)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1784130";"";"None";"416.38";"0";"3.60";"7m";"C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1787184";"Binding affinity to human NPYY1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1781958";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL1326298";"";"None";"428.58";"0";"4.53";"SID17511319";"CCc1cccc(CC)c1NC(=O)C(NS(=O)(=O)c1cccs1)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL157157";"";"None";"427.57";"0";"2.36";"5f";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccs2)CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL311229";"";"None";"427.57";"0";"3.88";"6";"Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750758";"In vitro binding affinity against rat neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL3191634";"";"None";"336.26";"0";"4.33";"SID24828877";"Brc1ccc(-c2csc(/N=C/N3CCCC3)n2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL411795";"";"None";"517.07";"2";"5.63";"10";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3CC2CCNCC2)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"15.08";"0.29";"2.17";"15.67";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238736";"";"None";"549.09";"2";"5.96";"27";"CN(C)C1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3C[C@@H]2CCNC[C@H]2F)C1";"IC50";"'='";"467.0";"nM";"6.33";"";"";"UO_0000065";"11.53";"0.22";"0.37";"12.73";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL567928";"";"None";"429.52";"0";"3.96";"2d";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3cccc(F)n3)n2)oc1C";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"20.54";"0.40";"4.86";"11.56";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1237044";"TRAMADOL";"4.0";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200679";"ZINC CHLORIDE";"4.0";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL227934";"STRYCHNINE";"-1.0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2106399";"KITASAMYCIN";"2.0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3.0";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL127";"MEROPENEM";"4.0";"383.47";"0";"-0.31";"MEROPENEM";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL515914";"AZARIBINE";"4.0";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2107797";"NORGESTREL";"4.0";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1381600";"";"None";"431.38";"1";"5.14";"SID24829477";"Cc1ccc(-[n+]2c(-c3ccccc3)cn3c2CCc2ccccc2-3)c(C)c1.[Br-]";"IC50";"'='";"3648.0";"nM";"5.44";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1531118";"";"None";"336.43";"0";"3.40";"SID17503911";"CCCCC(O)(CCCC)C(=O)NN(C(=O)OC)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1321154";"ROXARSONE";"None";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL426314";"";"None";"528.04";"2";"6.10";"1m";"O=C1c2c(n(CC3CCNCC3)c3ccccc23)[C@H](Oc2ccc(Cl)cc2)CC1N1CCC(F)(F)CC1";"IC50";"'='";"1862.09";"nM";"5.73";"";"";"UO_0000065";"10.85";"0.21";"-0.37";"12.32";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL288355";"";"None";"487.60";"0";"2.94";"10 (RS)";"CC(NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccc(O)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL187902";"";"None";"645.68";"2";"5.39";"6g";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3OC(F)(F)F)CC2)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"11.77";"0.23";"2.21";"5.68";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL311552";"";"None";"378.45";"1";"5.71";"40k";"CC(Cc1ccc(F)cc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"ONDANSETRON";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL585711";"";"None";"459.62";"0";"4.76";"2n";"Cc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc(CF)c(C)s3)n2)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"21.10";"0.43";"4.94";"15.35";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL568152";"";"None";"473.57";"0";"4.17";"2h";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCc3cccc(OCCF)n3)n2)oc1C";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"16.30";"0.32";"3.55";"9.03";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL566255";"";"None";"459.62";"0";"4.76";"2m";"Cc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc(C)c(CF)s3)n2)n1";"IC50";"'='";"0.56";"nM";"9.25";"";"";"UO_0000065";"20.13";"0.41";"4.49";"14.65";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2.0";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"2.01";"None";"None";"None";"0";"CHEMBL2320849";"Displacement of [125I]-NPY from Y1 receptor in human MCF7 cells in presence of 1 uM BBN";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311470";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308403";"";"";""
"CHEMBL566040";"";"None";"451.60";"0";"4.39";"2k";"Cc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc4c(o3)CCCC4)n2)n1";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"20.68";"0.40";"4.95";"12.24";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL162094";"";"None";"505.73";"1";"4.68";"2h";"Cc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"9.38";"0.18";"0.06";"7.72";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL311506";"";"None";"394.45";"1";"5.20";"44a";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccc(F)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL311159";"";"None";"421.45";"0";"4.97";"44c";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2cccc([N+](=O)[O-])c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL2252949";"(-)-CAMPHOR";"None";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL64";"ISONIAZID";"4.0";"137.14";"0";"-0.31";"INH";"NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL410792";"";"None";"2015.32";"None";"None";"20";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"159.0";"nM";"6.80";"";"";"UO_0000065";"3.37";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL350620";"";"None";"535.75";"1";"4.62";"2o";"COc1ccc2c(c1)CC(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"9600.0";"nM";"5.02";"";"";"UO_0000065";"9.37";"0.18";"0.40";"7.10";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4.0";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL442182";"";"None";"394.90";"1";"6.23";"40l";"CC(Cc1ccc(Cl)cc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"IC50";"'='";"0.3467";"nM";"9.46";"";"";"UO_0000065";"15.46";"0.29";"7.41";"5.01";"0";"CHEMBL3750352";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 5 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.1698";"nM";"9.77";"";"";"UO_0000065";"15.87";"0.30";"7.52";"5.22";"0";"CHEMBL3750352";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 5 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.1698";"nM";"9.77";"";"";"UO_0000065";"15.87";"0.30";"7.52";"5.22";"0";"CHEMBL3750353";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1024";"IFOSFAMIDE";"4.0";"261.09";"0";"1.88";"IFOSFAMIDE";"O=P1(NCCCl)OCCCN1CCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1480987";"CYCLANDELATE";"4.0";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL407030";"";"None";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL55";"PENTAMIDINE";"4.0";"340.43";"0";"2.88";"PENTAMIDINE";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL381510";"";"None";"524.08";"2";"6.19";"1l";"CC1(F)CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CC3CCNCC3)C2=O)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.36";"0.26";"0.81";"15.05";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1836318";"";"None";"437.66";"0";"4.37";"16";"CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837821";"Antagonist activity at human NPY1 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2046864";"";"None";"378.56";"1";"5.31";"1a";"CCOc1cccc([C@]2(N3CCN(c4ccccc4)CC3)CC[C@@H](C)CC2)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"18.28";"0.34";"1.61";"44.05";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL410938";"";"None";"2004.29";"None";"None";"16";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"398.0";"nM";"6.40";"";"";"UO_0000065";"3.19";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL411800";"";"None";"1917.26";"None";"None";"25";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](CN[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1091.0";"nM";"5.96";"";"";"UO_0000065";"3.11";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1452153";"";"None";"425.37";"0";"4.36";"SID17412522";"Cc1ccc(C(=O)C[n+]2cc(-c3ccccc3)n3c2CCCCC3)cc1.[Br-]";"IC50";"'='";"6057.0";"nM";"5.22";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1370771";"";"None";"400.87";"0";"3.47";"SID24783064";"COc1ccc(C2N(c3ccc(Cl)cc3)N=C(C(C)=O)N(C)N2C(C)=O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1370128";"";"None";"488.08";"1";"5.49";"SID22403138";"O=C(C1CCN(Cc2ccc(Cl)cc2)CC1)N1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1579872";"";"None";"379.28";"0";"4.10";"SID7967138";"Cc1cccc(CSC2=NCCN2C(=O)c2ccc(Br)o2)c1";"IC50";"'<'";"12000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1329549";"";"None";"496.59";"0";"4.59";"SID17511337";"CCOC(=O)CCCCC(=O)c1[nH]c(O)nc1CSc1nnc2c3ccccc3n(C(C)C)c2n1";"IC50";"'='";"7628.0";"nM";"5.12";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377743";"";"None";"338.86";"0";"4.00";"SID14725303";"Clc1ccc(OCCSc2nnnn2C2CCCCC2)cc1";"IC50";"'='";"9045.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1514";"nM";"9.82";"";"";"UO_0000065";"16.29";"0.30";"7.54";"5.33";"0";"CHEMBL3750540";"Displacement of (R)-Na-Diphenylacetyl-Nomega[2-([2,3-3H]-propionylamino)ethyl]aminocarbonyl (4-hydroxybenzyl)-argininamide from NPY1R in human SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307551";"";"";""
"CHEMBL4299523";"";"None";"4253.71";"None";"None";"pNPY";"CC[C@@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@H](C)CC";"IC50";"'='";"1.778";"nM";"8.75";"";"";"UO_0000065";"2.06";"None";"None";"None";"0";"CHEMBL3750363";"Displacement of (R)-Na-Diphenylacetyl-Nomega[2-([2,3-3H]-propionylamino)ethyl]aminocarbonyl (4-hydroxybenzyl)-argininamide from NPY1R in human SK-N-MC cells preincubated with radioligand followed by protein addition for 60 mins by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307551";"";"";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4.0";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL205596";"CHOLIC ACID";"4.0";"408.58";"0";"3.45";"CHOLIC ACID";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL34431";"CILOSTAMIDE";"2.0";"342.44";"0";"3.48";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"Haloperidol";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201151";"MESTRANOL";"4.0";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL44884";"ETHAMBUTOL";"4.0";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909048";"";"None";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4.0";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL119443";"ERGONOVINE";"4.0";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1076211";"TOLPERISONE";"3.0";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL437027";"BOMBESIN";"1.0";"1619.88";"None";"None";"BBN";"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(N)=O";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"5.14";"None";"None";"None";"0";"CHEMBL2320847";"Displacement of [125I]-NPY from Y1 receptor in human MCF7 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311470";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308403";"";"";""
"CHEMBL828";"PHENOTHIAZINE";"2.0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1836316";"";"None";"491.73";"1";"5.47";"14";"O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837821";"Antagonist activity at human NPY1 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL165556";"";"None";"551.75";"1";"4.38";"2f";"COc1cc2c(cc1OC)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"8.64";"0.17";"0.39";"5.97";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL252557";"GLYCOLIC ACID";"2.0";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2046867";"";"None";"376.54";"0";"4.78";"2";"CCOc1cccc([C@]2(N3CCN(c4ccccc4)CC3)[C@@H]3C[C@@H](C)C[C@@H]32)c1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"19.14";"0.35";"2.43";"45.88";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL398440";"CHLOROXYLENOL";"4.0";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL762";"OXYMETAZOLINE";"4.0";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"ALBENDAZOLE";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL9514";"NOCODAZOLE";"2.0";"301.33";"0";"3.03";"NOCODAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL485549";"NIFURSOL";"2.0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"None";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"1.23";"nM";"8.91";"";"";"UO_0000065";"16.36";"0.30";"6.17";"5.64";"0";"CHEMBL3750349";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 secs by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"PREDNISOLONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1419";"SIBUTRAMINE";"4.0";"279.86";"0";"4.74";"sibutramine";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL438411";"";"None";"4224.71";"None";"None";"3";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"IC50";"'='";"2.69";"nM";"8.57";"";"";"UO_0000065";"2.03";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL438096";"";"None";"2004.29";"None";"None";"15";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL428320";"";"None";"1954.28";"None";"None";"13";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"76.95";"nM";"7.11";"";"";"UO_0000065";"3.64";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL203430";"";"None";"521.06";"1";"4.14";"1n";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CC3CCNCC3)C2=O)CC1=O";"IC50";"'='";"3890.45";"nM";"5.41";"";"";"UO_0000065";"10.38";"0.20";"1.27";"8.10";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL382836";"";"None";"506.09";"2";"6.10";"1k-1";"CC1CCN([C@H]2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CC3CCNCC3)C2=O)CC1";"IC50";"'='";"22.39";"nM";"7.65";"";"";"UO_0000065";"15.12";"0.29";"1.55";"16.45";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL205261";"";"None";"535.13";"2";"5.40";"1h";"CNC1CCC(Cn2c3c(c4ccccc42)C(=O)C(N2CCN(C)CC2)C[C@H]3Oc2ccc(Cl)cc2)CC1";"IC50";"'='";"93.33";"nM";"7.03";"";"";"UO_0000065";"13.14";"0.25";"1.63";"14.13";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL203433";"";"None";"535.13";"2";"5.49";"1b";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CCCN3CCCCC3)C2=O)CC1";"IC50";"'='";"1318.26";"nM";"5.88";"";"";"UO_0000065";"10.99";"0.21";"0.39";"14.36";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1543306";"";"None";"446.62";"1";"5.43";"SID17507305";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"14.87";"0.28";"5.36";"5.13";"0";"CHEMBL3750539";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 300 nM pNPY-induced Ca+2 response preincubated for 15 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"8.24";"nM";"8.08";"";"";"UO_0000065";"13.41";"0.25";"5.80";"4.39";"0";"CHEMBL3750539";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 300 nM pNPY-induced Ca+2 response preincubated for 15 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"7.61";"nM";"8.12";"";"";"UO_0000065";"13.19";"0.25";"5.87";"4.34";"0";"CHEMBL3750539";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 300 nM pNPY-induced Ca+2 response preincubated for 15 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.7079";"nM";"9.15";"";"";"UO_0000065";"15.18";"0.28";"6.87";"4.97";"0";"CHEMBL3750350";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 1 min by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"18.36";"0.34";"7.26";"6.33";"0";"CHEMBL3750353";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL428292";"";"None";"1917.26";"None";"None";"31";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](CN[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)CC(C)C";"IC50";"'='";"735.0";"nM";"6.13";"";"";"UO_0000065";"3.20";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL412704";"";"None";"1917.26";"None";"None";"23";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1487131";"";"None";"335.44";"0";"4.12";"SID845226";"CC(C)c1ccc(-c2nnn(Cc3nc4ccccc4s3)n2)cc1";"IC50";"'='";"5680.0";"nM";"5.25";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1200748";"CARBIDOPA";"4.0";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL268409";"";"None";"1991.34";"None";"None";"22";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(N)=O)C(c1ccccc1)c1ccccc1)[C@@H](C)O)C(C)C";"IC50";"'='";"1248.0";"nM";"5.90";"";"";"UO_0000065";"2.96";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL2397293";"";"None";"379.51";"0";"2.96";"12";"CCOc1cccc(C2(N3CCN(c4ncncn4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"4270.0";"nM";"5.37";"";"";"UO_0000065";"14.15";"0.26";"2.41";"9.87";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL49461";"";"None";"571.19";"2";"8.13";"2p";"CCc1sc(CCc2cc(OC3CCCCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL48947";"";"None";"517.10";"2";"6.82";"2b";"CCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL2397296";"";"None";"378.52";"0";"3.57";"15";"CCOc1cccc(C2(N3CCN(c4cncnc4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"5032.0";"nM";"5.30";"";"";"UO_0000065";"14.00";"0.26";"1.73";"12.77";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397292";"";"None";"391.56";"0";"4.36";"11";"CCOc1cccc(C2(N3CCN(c4ccccc4N)CC3)C3CC(C)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397200";"";"None";"378.52";"0";"3.57";"8";"CCOc1cccc(C2(N3CCN(c4cnccn4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"265.0";"nM";"6.58";"";"";"UO_0000065";"17.37";"0.32";"3.01";"15.85";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397302";"";"None";"412.97";"0";"4.22";"7";"CCOc1cccc(C2(N3CCN(c4ccc(Cl)nn4)CC3)C3CC(C)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397301";"";"None";"300.45";"0";"2.86";"4";"CCOc1cccc(C2(N3CCNCC3)C3CC(C)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2046859";"";"None";"366.94";"1";"5.03";"10";"C[C@@H]1C[C@@H]2[C@H](C1)[C@@]2(c1cccc(Cl)c1)N1CCN(c2ccccc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2051172";"Displacement of [125I]peptideYY from NPY1 receptor in human SK-N-MC cells after 1 hr by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046295";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"CHEMBL3307551";"";"";""
"CHEMBL562677";"";"None";"374.49";"0";"2.62";"2e";"CCc1oc(CCc2cc(N3CCOCC3)cc(NCCOC)n2)nc1C";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1365675";"AMITRAZ";"2.0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"PROMETHAZINE";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"HYDROCORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"KETOTIFEN";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL510139";"CITRININ";"None";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"FLUCONAZOLE";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1521";"ZALEPLON";"4.0";"305.34";"0";"2.64";"ZALEPLON";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201117";"METHOCARBAMOL";"4.0";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201237";"LEVOBUNOLOL";"4.0";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"None";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL263350";"";"None";"1927.25";"None";"None";"8";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1Cc2ccccc2CC1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL936";"DIPHENIDOL";"4.0";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"-1.0";"259.35";"0";"2.58";"SID11113604";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL991";"STAVUDINE";"4.0";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"RESVERATROL";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL49461";"";"None";"571.19";"2";"8.13";"2p";"CCc1sc(CCc2cc(OC3CCCCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"13.20";"0.26";"-0.59";"8.83";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL441007";"";"None";"3840.43";"None";"None";"43";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"1.81";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL86304";"MOCLOBEMIDE";"4.0";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL266021";"";"None";"1931.24";"None";"None";"40";"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1586.0";"nM";"5.80";"";"";"UO_0000065";"3.00";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL411200";"";"None";"2004.29";"None";"None";"41";"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"183.0";"nM";"6.74";"";"";"UO_0000065";"3.36";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL411637";"";"None";"2077.35";"None";"None";"37";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"233.0";"nM";"6.63";"";"";"UO_0000065";"3.19";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL43064";"CINNARIZINE";"4.0";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL48897";"";"None";"593.19";"2";"8.04";"2s";"CCc1sc(CCc2cc(OCCc3ccccc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.68";"0.25";"-0.52";"8.81";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1537995";"";"None";"359.90";"1";"5.75";"SID17409726";"Cc1nc(-c2ccccc2)sc1C(=O)CSc1ccc(Cl)cc1";"IC50";"'='";"5404.0";"nM";"5.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL41686";"";"None";"518.06";"1";"4.02";"27 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)N[C@H]1CCc2ccccc21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL1423799";"";"None";"372.28";"1";"5.61";"SID17503768";"N#Cc1ccc(-c2cccnc2)nc1SCc1ccc(Cl)c(Cl)c1";"IC50";"'='";"5687.0";"nM";"5.25";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1559259";"";"None";"392.44";"0";"4.06";"SID14745482";"COC(=O)c1ccc(CSc2nc3ccccc3c(=O)n2-c2ccccc2)o1";"IC50";"'='";"5210.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL405527";"";"None";"1991.34";"None";"None";"34";"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"275.0";"nM";"6.56";"";"";"UO_0000065";"3.29";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL429698";"";"None";"1965.30";"None";"None";"11";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"88.3";"nM";"7.05";"";"";"UO_0000065";"3.59";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL9419";"METACETAMOL";"2.0";"151.16";"0";"1.35";"3-ACETAMIDOPHENOL";"CC(=O)Nc1cccc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL61";"PODOFILOX";"4.0";"414.41";"0";"2.41";"4";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1255834";"BW-723C86";"None";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL307145";"PYROGALLOL";"4.0";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL115722";"";"None";"583.80";"2";"5.15";"2e (dihydropyridine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(S)=N/CCCN2CCN(C3CCCCC3)CC2)c1";"IC50";"'='";"132.0";"nM";"6.88";"";"";"UO_0000065";"11.78";"0.23";"1.73";"6.95";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL406128";"";"None";"1917.26";"None";"None";"30";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"None";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL48493";"";"None";"587.23";"2";"8.77";"2g";"CCCCCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL48950";"";"None";"545.15";"2";"7.60";"2d";"CCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"14.30";"0.29";"0.20";"9.13";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1345334";"";"None";"340.43";"1";"5.26";"SID17402173";"COc1ccc(Cn2c(/C=C/c3ccccc3)nc3ccccc32)cc1";"IC50";"'='";"4021.0";"nM";"5.40";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL264820";"";"None";"557.16";"2";"7.74";"2o";"CCc1sc(CCc2cc(OC3CCCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.28";"0.29";"0.22";"9.32";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL48456";"";"None";"559.18";"2";"7.99";"2e";"CCCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"13.33";"0.27";"-0.53";"8.73";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1349920";"";"None";"244.32";"0";"3.23";"SID14720926";"CCSc1nc2ccc(OC)cc2cc1C#N";"IC50";"'='";"11150.0";"nM";"4.95";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468302";"";"None";"415.35";"1";"5.34";"SID17516282";"Nn1c(Cc2cccc3ccccc23)nnc1SCc1c(Cl)cccc1Cl";"IC50";"'='";"5100.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL403";"SULBACTAM";"4.0";"233.24";"0";"-0.79";"Sulbactam";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL434063";"";"None";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL395110";"MEPAZINE";"4.0";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL460499";"CARMOFUR";"2.0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL52282";"";"None";"543.13";"2";"7.35";"2n";"CCc1sc(CCc2cc(OC3CCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.65";"0.29";"0.61";"9.32";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL862";"GUANFACINE";"4.0";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL290916";"EDARAVONE";"4.0";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL413232";"";"None";"1917.26";"None";"None";"29";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](CN[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)Cc1ccc(O)cc1";"IC50";"'='";"1270.0";"nM";"5.90";"";"";"UO_0000065";"3.08";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL595";"PIOGLITAZONE";"4.0";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL174";"AMPICILLIN";"4.0";"349.41";"0";"0.32";"AMPICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3746870";"";"None";"616.72";"2";"2.67";"7";"CCOC(=O)CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.3311";"nM";"9.48";"";"";"UO_0000065";"15.37";"0.29";"6.81";"5.15";"0";"CHEMBL3750351";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 2 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.4169";"nM";"9.38";"";"";"UO_0000065";"15.23";"0.28";"7.13";"5.01";"0";"CHEMBL3750351";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 2 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"1a; BIBP3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"16.22";"nM";"7.79";"";"";"UO_0000065";"16.45";"0.30";"5.41";"5.45";"0";"CHEMBL3750352";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 5 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1698";"nM";"9.77";"";"";"UO_0000065";"16.21";"0.30";"7.49";"5.30";"0";"CHEMBL3750352";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 5 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL77770";"";"None";"403.53";"1";"5.43";"44h";"CCN(c1ccccc1)c1ccc(NC(=O)N(C)[C@H](C)[C@@H](O)c2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4.0";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"Nifedipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL600325";"PROSCILLARIDIN";"4.0";"530.66";"1";"3.01";"PROSCILLARIDIN";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909075";"";"None";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"Methotrexate, MTX";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL56337";"EPALRESTAT";"4.0";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1460";"DIDANOSINE";"4.0";"236.23";"0";"-0.21";"DIDANOSINE";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1231107";"CYROMAZINE";"2.0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL476";"DACARBAZINE";"4.0";"182.19";"0";"0.07";"DACARBAZINE";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201203";"BENZTROPINE";"4.0";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL162093";"";"None";"521.73";"1";"4.38";"2d";"COc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"9.30";"0.18";"0.47";"6.87";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL48456";"";"None";"559.18";"2";"7.99";"2e";"CCCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1527817";"";"None";"391.29";"0";"3.82";"SID864669";"Clc1ccc(C2=Nn3c(nnc3-c3[nH]nc4c3CCC4)SC2)cc1Cl";"IC50";"'='";"9798.0";"nM";"5.01";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1082723";"CIPARGAMIN";"2.0";"390.24";"0";"4.34";"NITD609";"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1247903";"Binding affinity to human recombinant neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240532";"1";"Scientific Literature";"Science";"2010";"None";"";"";""
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL540466";"";"None";"581.75";"2";"5.97";"3i";"COc1ccc([C@H](N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)C(F)F)cc1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1053232";"Antagonist activity at human neuropeptide Y1 receptor expressed in HEK293 cells by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153458";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";"";"";""
"CHEMBL557648";"";"None";"358.49";"0";"3.38";"2d";"CCc1oc(CCc2cc(N3CCOCC3)cc(NC(C)C)n2)nc1C";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL12131";"CLOSANTEL";"2.0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL571013";"";"None";"330.43";"0";"2.60";"2b";"CCc1oc(CCc2cc(N3CCOCC3)cc(NC)n2)nc1C";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4.0";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL720";"BENZYL ALCOHOL";"4.0";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1221512";"";"None";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL70586";"SPIRADOLINE";"None";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"METOCLOPRAMIDE";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1499276";"";"None";"396.45";"1";"5.23";"SID17412710";"Cc1ccc(-c2cc(C(=O)Nc3ccc4c(c3)OCCO4)c3ccccc3n2)cc1";"IC50";"'='";"5010.0";"nM";"5.30";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1439981";"";"None";"349.39";"0";"4.40";"SID863565";"COc1ccc(-c2nc(C#N)c(NC(C)c3ccccc3)o2)cc1OC";"IC50";"'='";"7767.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL116230";"";"None";"591.71";"2";"5.15";"2f (dihydropyrazine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)N1c1cccc(NC(=O)NCCCN2CCC(c3cccc(OC)c3)CC2)c1";"IC50";"'='";"554.0";"nM";"6.26";"";"";"UO_0000065";"10.57";"0.20";"1.11";"5.01";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL560921";"";"None";"369.47";"0";"2.89";"2g";"CCc1oc(CCc2cc(N3CCOCC3)cc(NCCC#N)n2)nc1C";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL560382";"";"None";"375.52";"0";"3.22";"3d";"Cc1nc(SCc2cc(N3CCOCC3)cc(NCC#N)n2)sc1C";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1055592";"Displacement of [125I]PYY from human recombinant NPY Y1 receptor expressed in CHO cells assessed as inhibition of [35S]GTPgammaS binding by scintillation counting";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152970";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL1413";"CICLOPIROX";"4.0";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1177";"PEMOLINE";"4.0";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL878";"METOLAZONE";"4.0";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL277100";"TEMAFLOXACIN";"4.0";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL386630";"TESTOSTERONE";"4.0";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1065";"METHYSERGIDE";"None";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"TERBUTALINE";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL625";"THIABENDAZOLE";"4.0";"201.25";"0";"2.69";"THIABENDAZOLE";"c1ccc2[nH]c(-c3cscn3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"1e, AVLB";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1261";"CITRIC ACID";"4.0";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL86754";"IODOQUINOL";"2.0";"396.95";"0";"3.15";"IODOQUINOL";"Oc1c(I)cc(I)c2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL844";"BRIMONIDINE";"4.0";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL564201";"6-AZAURIDINE";"None";"245.19";"0";"-3.46";"AZAURIDINE";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL154412";"";"None";"471.60";"0";"3.45";"6a";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1)c1cc2ccccc2s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1502";"PANTOPRAZOLE";"4.0";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL290106";"BITHIONOL";"4.0";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL383763";"";"None";"539.10";"1";"4.91";"1s";"CN1CCN(C2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3C[C@@H]3CCN(C)C[C@@H]3F)C2=O)CC1";"IC50";"'='";"169.82";"nM";"6.77";"";"";"UO_0000065";"12.56";"0.24";"1.86";"16.53";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL439506";"";"None";"507.08";"1";"4.62";"1i-1";"CN1CCN([C@H]2C[C@@H](Oc3ccc(Cl)cc3)c3c(c4ccccc4n3CC3CCNCC3)C2=O)CC1";"IC50";"'='";"48.98";"nM";"7.31";"";"";"UO_0000065";"14.42";"0.28";"2.69";"14.70";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"DIGOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201469";"GRAMICIDIN";"4.0";"None";"None";"None";"GRAMICIDIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1501";"FLUOCINONIDE";"4.0";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4.0";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1908355";"TENIDAP";"2.0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL245416";"L-MIMOSINE";"None";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"Alprazolam";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1902981";"EPERISONE";"3.0";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL15245";"YOHIMBINE";"4.0";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL53463";"DOXORUBICIN";"4.0";"543.53";"3";"0.00";"Doxorubicin";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4.0";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1618305";"NALOXONAZINE";"None";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL13341";"NIMETAZEPAM";"2.0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"None";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"MICONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL134342";"THIOCTIC ACID";"None";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL902";"FAMOTIDINE";"4.0";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL101168";"";"None";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1572";"NETILMICIN";"4.0";"475.59";"2";"-3.20";"NETILMICIN";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL954";"ENCLOMIPHENE";"3.0";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1220";"TINIDAZOLE";"4.0";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1466";"DICUMAROL";"4.0";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL29";"BENZYLPENICILLIN";"4.0";"334.40";"0";"0.86";"PENICILLIN G";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"indomethacin";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL877";"TRANEXAMIC ACID";"4.0";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL159";"VINBLASTINE";"4.0";"810.99";"2";"3.99";"VINBLASTINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"GLYBURIDE";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL36994";"ANIRACETAM";"2.0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL195437";"4-OCTYLPHENOL";"None";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4.0";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201346";"BALSALAZIDE";"4.0";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0.5";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL40";"PHENOBARBITAL";"4.0";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1359694";"";"None";"294.35";"0";"3.56";"SID22404799";"CCCCOc1nc2ccccc2c(=O)n1-c1ccccc1";"IC50";"'='";"13220.0";"nM";"4.88";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1870697";"";"None";"464.11";"1";"5.51";"SID17503795";"O=C(Nc1cccc(/N=C/c2cc(Br)cc(Br)c2O)c1)c1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1481";"GLIMEPIRIDE";"4.0";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL628";"PENTOXIFYLLINE";"4.0";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL437";"SULFATHIAZOLE";"4.0";"255.32";"0";"1.53";"SULFATHIAZOLE";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1726";"NISOLDIPINE";"4.0";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"NALOXONE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL502620";"ACLARUBICIN";"3.0";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1360426";"";"None";"405.44";"0";"3.22";"SID7967518";"COc1ccc(-c2nnc3sc(C(C)N4C(=O)c5ccccc5C4=O)nn23)cc1";"IC50";"'='";"9350.0";"nM";"5.03";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342925";"";"None";"370.79";"0";"4.69";"SID22400580";"COC(=O)c1cc2occc2n1Cc1nc(-c2ccccc2Cl)oc1C";"IC50";"'='";"7704.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1383592";"";"None";"346.81";"0";"3.09";"SID17506366";"Cc1ccc(NC(=O)C(=O)NCCOc2ccc(Cl)cc2)c(C)c1";"IC50";"'='";"7387.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1402158";"";"None";"366.46";"1";"5.12";"SID17432207";"Cc1ccccc1/C=C/c1nc2ccccc2c(=O)n1CCc1ccccc1";"IC50";"'='";"4261.0";"nM";"5.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3195213";"";"None";"371.26";"0";"2.79";"SID22403229";"CCc1nnc(S)n1/N=C/c1cc(Br)c(OC)cc1OC";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427860";"";"None";"470.59";"1";"6.33";"SID17413034";"Cc1ccc(C)c(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3-c3ccccc3)ccc2C)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1353075";"";"None";"354.47";"0";"2.66";"SID22412085";"CCCCCCNS(=O)(=O)c1ccc(NC(=O)C2CCCO2)cc1";"IC50";"'='";"13680.0";"nM";"4.86";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1353428";"";"None";"377.51";"0";"4.56";"SID17514938";"Cc1cccc(-n2ccnc2SCC(=O)N2CCCc3ccccc32)c1C";"IC50";"'='";"4084.0";"nM";"5.39";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1351633";"";"None";"349.88";"0";"4.08";"SID17506323";"Cc1cccc(CSCCNC(=O)COc2ccc(Cl)cc2)c1";"IC50";"'='";"13340.0";"nM";"4.88";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312703";"";"None";"375.85";"0";"4.69";"SID17412693";"COC(=O)c1cc(Cl)c(NC(=O)c2ccc(C(C)(C)C)cc2)cc1OC";"IC50";"'='";"5306.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1574689";"";"None";"390.49";"0";"3.55";"SID3712225";"COC(=O)c1ccc(CSc2nc3sc4c(c3c(=O)n2C)CCCC4)o1";"IC50";"'='";"6952.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1446166";"";"None";"314.80";"0";"4.72";"SID17410323";"O=C(Nc1ccc(Cl)cc1)c1csc(-c2ccccc2)n1";"IC50";"'='";"6943.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1300782";"";"None";"387.28";"0";"4.47";"SID17403121";"CCC1=Nc2ccc(Br)cc2C(c2ccccc2)N1CC(=O)OC";"IC50";"'='";"13170.0";"nM";"4.88";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3211272";"";"None";"317.85";"0";"3.38";"SID17515043";"S=C(NCCc1ccccc1)N/N=C/c1ccccc1Cl";"IC50";"'='";"5022.0";"nM";"5.30";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1423382";"";"None";"444.48";"1";"5.37";"SID17506930";"CCC(Oc1ccc2c(=O)c(-c3ccccc3OC)coc2c1)C(=O)OCc1ccccc1";"IC50";"'='";"11510.0";"nM";"4.94";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1453672";"";"None";"407.47";"1";"5.82";"SID22405717";"O=C(COC(=O)c1ccc(-c2ccccc2)cc1)Nc1ccccc1-c1ccccc1";"IC50";"'='";"5724.0";"nM";"5.24";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1385608";"";"None";"528.61";"2";"7.75";"SID17386306";"O=P(CCCCCCCCCP(=O)(c1ccccc1)c1ccccc1)(c1ccccc1)c1ccccc1";"IC50";"'='";"10400.0";"nM";"4.98";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1426022";"";"None";"357.93";"0";"4.34";"SID17507949";"Cl.OC1(c2ccccc2)CCN(Cc2ccccc2)C2CCCCC21";"IC50";"'='";"10170.0";"nM";"4.99";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1201049";"ECONAZOLE NITRATE";"4.0";"444.70";"1";"5.80";"SID855519";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O";"IC50";"'='";"5146.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1522356";"";"None";"373.31";"1";"5.84";"SID17410088";"Clc1ccc(CSc2cc3c(nn2)-c2ccccc2CC3)cc1Cl";"IC50";"'='";"5266.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL262083";"N6-PHENYLADENOSINE";"None";"343.34";"0";"0.18";"SID855897";"OC[C@H]1O[C@@H](n2cnc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"7826.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312713";"";"None";"394.52";"0";"4.22";"SID14720874";"CCN(CC)CC(O)COc1ccc2c(c1)c(C(C)=O)c(C)n2-c1ccccc1";"IC50";"'='";"4368.0";"nM";"5.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL18797";"SULINDAC SULFIDE";"-1.0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1289";"HALOPROGIN";"4.0";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1262";"OXICONAZOLE";"4.0";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"None";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1909069";"";"None";"None";"None";"None";"MC 288769";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200391";"TROMETHAMINE";"4.0";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2221249";"COLISTIN";"4.0";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1566249";"AMPIROXICAM";"2.0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"Ethosuximide";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"aspirin";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL24441";"BETAHISTINE";"4.0";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3084803";"ASTROMICIN";"-1.0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL267744";"TICRYNAFEN";"4.0";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL588119";"SULOCTIDIL";"None";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1619";"CLADRIBINE";"4.0";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL727";"THIOGUANINE";"4.0";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL93";"ZILEUTON";"4.0";"236.30";"0";"2.73";"ZILEUTON";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL378587";"";"None";"522.09";"2";"5.58";"1d";"O=C1c2c(n(CCCN3CCCCC3)c3ccccc23)[C@H](Oc2ccc(Cl)cc2)CC1N1CCOCC1";"IC50";"'='";"15848.93";"nM";"4.80";"";"";"UO_0000065";"9.19";"0.18";"-0.78";"10.23";"0";"CHEMBL867214";"Displacement of [125I]PYY from human recombinant NPY1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308072";"";"";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4.0";"None";"None";"None";"POLYVINYL ALCOHOL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL561";"LOMEFLOXACIN";"4.0";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL269732";"TACROLIMUS ANHYDROUS";"4.0";"804.03";"2";"4.64";"tacrolimus";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4.0";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL76904";"TYRPHOSTIN 23";"None";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"ASTEMIZOLE";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL153522";"";"None";"550.50";"1";"4.21";"6b";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Br)cc2)CC1)c1cc2ccccc2s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1456185";"";"None";"254.34";"0";"2.83";"SID4259551";"C=CCNc1nc(N2CCCC2)nc2ccccc12";"IC50";"'='";"11810.0";"nM";"4.93";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1457093";"";"None";"382.89";"0";"3.99";"SID14732060";"Cl.O=C(COc1ccccc1CNCc1ccccc1)Nc1ccccc1";"IC50";"'='";"5161.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1389982";"";"None";"311.38";"1";"5.25";"SID17386276";"Oc1cccc(-c2nc3ccc4ccccc4c3c3c2CCC3)c1";"IC50";"'='";"7683.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1453776";"";"None";"390.49";"0";"3.42";"SID14736687";"CCOc1ccc2nc(NC(=O)CS(=O)(=O)c3ccc(C)cc3)sc2c1";"IC50";"'>'";"12000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL38";"TRETINOIN";"4.0";"300.44";"1";"5.60";"TRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL506247";"TANNIC ACID";"4.0";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1237174";"HYDRAZINE";"0.5";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1447";"LINCOMYCIN";"4.0";"406.55";"0";"-0.86";"LINCOMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"2.30";"None";"None";"None";"0";"CHEMBL947365";"Displacement of radiolabeled NPY from human neuropeptide Y1 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140203";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL157905";"";"None";"472.59";"0";"2.84";"5g";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3cccnc23)CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL564979";"";"None";"395.31";"1";"5.51";"SID17513473";"Cc1ccc(CCC(=O)Nc2ncc(Cc3cc(Cl)ccc3Cl)s2)o1";"IC50";"'='";"7273.0";"nM";"5.14";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1467233";"";"None";"478.93";"1";"5.31";"SID14737781";"CCOc1ccc(-n2cc(C(=O)Nc3cccc(Cl)c3)c3cc(OC)c(OC)cc3c2=O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1366620";"";"None";"343.29";"0";"4.15";"SID22404149";"CCCCCC(=O)NC(=S)Nc1ccc(Br)cc1C";"IC50";"'='";"7662.0";"nM";"5.12";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1507807";"";"None";"462.34";"1";"6.45";"SID14729317";"O=C(CCc1nc(-c2ccccc2)c(-c2ccccc2)o1)OCc1ccc(Br)cc1";"IC50";"'='";"8364.0";"nM";"5.08";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL417727";"";"None";"223.23";"0";"2.31";"SID14730721";"Nc1ccc2c(c1)C(=O)C(=O)c1ccccc1-2";"IC50";"'='";"4542.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL566889";"";"None";"473.62";"0";"3.53";"4b";"Cc1cccc(CNc2cc(N3CCS(=O)(=O)CC3)cc(CSc3nc(C)c(C)o3)n2)n1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"18.52";"0.37";"5.24";"8.66";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"CHLORAMPHENICOL";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"None";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4.0";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4.0";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1771260";"";"None";"478.42";"0";"4.90";"2g";"CCOc1cc(Cl)c(-c2c(C)nn3c(NCCNC4CCOCC4)cc(C)nc23)c(Cl)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1771963";"Antagonist activity at NPY Y1 receptor in human SK-N-MC cells assessed as inhibition of NPY-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1770105";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3307551";"";"";""
"CHEMBL189548";"";"None";"615.74";"1";"4.17";"BMS-245782";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCCN2CCN(c3cccc(OC)c3)CC2)NC#N)c1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"12.03";"0.22";"3.24";"5.14";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL56564";"TROPISETRON";"4.0";"284.36";"0";"2.95";"Tropisetron ICS-205-930";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL75435";"DEXKETOPROFEN";"4.0";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL24944";"TRIBROMSALAN";"4.0";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"METHIMAZOLE";"Cn1ccnc1S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1.0";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL350684";"";"None";"522.65";"1";"4.00";"6g";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3cccnc23)CC1)c1cc2ccccc2s1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL585669";"";"None";"441.63";"0";"4.85";"3b";"Cc1cccc(CNc2cc(N3CCSCC3)cc(CSc3nc(C)c(C)o3)n2)n1";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"22.18";"0.45";"4.95";"14.60";"0";"CHEMBL1042012";"Displacement of [125I]-PYY from human NPYY1 receptor overexpressed in CHO cell membrane after 120 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3308072";"";"";""
"CHEMBL264820";"";"None";"557.16";"2";"7.74";"2o";"CCc1sc(CCc2cc(OC3CCCC3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL45869";"";"None";"579.17";"2";"8.00";"2r";"CCc1sc(CCc2cc(OCc3ccccc3)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL161724";"";"None";"362.43";"0";"4.20";"1";"CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1";"IC50";"'>>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747052";"Inhibitory activity against Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145972";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL290261";"";"None";"483.62";"0";"3.45";"22 (S)";"N=C(N)NCCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@H]1CCc2ccccc21";"IC50";"";"";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL290175";"";"None";"631.82";"2";"5.38";"32";"N/C(=N/CCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2cc(O)ccc2C1)NCCCc1ccccc1";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"7.37";"0.14";"-0.72";"3.88";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL871";"ETIDRONIC ACID";"4.0";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL364380";"";"None";"601.71";"1";"3.91";"3h";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3O)CC2)NC#N)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.80";"0.26";"4.39";"5.07";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL360205";"";"None";"577.68";"1";"4.19";"6h";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3O)CC2)c1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.23";"0.27";"4.03";"5.68";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL422150";"";"None";"421.54";"0";"2.29";"5a";"O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"ARTEMISININ";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1536";"ERGOCALCIFEROL";"4.0";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL60737";"";"None";"408.59";"1";"5.29";"66";"CC[C@H]1CC[C@@](c2cccc(OCOC)c2)(N2CCN(c3ccccc3)CC2)CC1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"18.13";"0.34";"2.12";"29.71";"0";"CHEMBL747050";"The compound was tested for the binding affinity against Neuropeptide Y receptor type 1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132409";"1";"Scientific Literature";"J Med Chem";"1999";"None";"";"";""
"CHEMBL1006";"AMIFOSTINE";"4.0";"214.23";"0";"-0.25";"AMIFOSTINE";"NCCCNCCSP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL164897";"";"None";"476.69";"1";"5.32";"1";"O=S(=O)(NC[C@H]1CC[C@@H](CNCC2CCc3ccccc3C2)CC1)c1cccc2ccccc12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.35";"0.24";"0.57";"10.11";"0";"CHEMBL756256";"Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136061";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"None";"";"";""
"CHEMBL298983";"";"None";"531.12";"2";"7.20";"2i";"CCc1sc(CCc2cc(OC(C)C)cc(NCc3cc(Cl)cc(NC(=O)OC(C)C)c3)n2)nc1C";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4.0";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL154168";"";"None";"547.79";"2";"5.66";"5e";"CC(C)c1cc(C(C)C)c(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cccs3)CC2)c(C(C)C)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL4794692";"";"None";"750.17";"2";"2.07";"59";"N/C(=N/C(=O)NCCNC(=O)CCl)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.07943";"nM";"10.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4762044";"";"None";"755.79";"2";"2.64";"69";"N/C(=N/C(=O)NCCNC(=O)C1CCC1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.2399";"nM";"9.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4792205";"";"None";"777.80";"2";"3.15";"73";"N/C(=N/C(=O)NCCNC(=O)c1ccccc1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"11.48";"nM";"7.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL240038";"";"None";"563.12";"2";"6.40";"31";"CN1CCCC1CCNC(=O)c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@H]1F";"IC50";"'='";"1862.0";"nM";"5.73";"";"";"UO_0000065";"10.18";"0.20";"-0.67";"9.79";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238733";"";"None";"561.10";"2";"6.11";"26";"O=C(c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@H]1F)N1CCN(C2CC2)CC1";"IC50";"'='";"871.0";"nM";"6.06";"";"";"UO_0000065";"10.80";"0.21";"-0.05";"12.18";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL238527";"";"None";"536.05";"2";"5.78";"25";"O=C(c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@@H]1F)N1CCC(O)CC1";"IC50";"'='";"7762.0";"nM";"5.11";"";"";"UO_0000065";"9.53";"0.18";"-0.67";"7.66";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL392943";"";"None";"531.10";"2";"5.97";"11";"CN1CCC(Cn2c3ccccc3c3cc(C(=O)N4CCN(C)CC4)cc(Oc4ccc(Cl)cc4)c32)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.99";"0.29";"1.99";"19.43";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL583";"GREPAFLOXACIN";"4.0";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL324990";"";"None";"606.79";"2";"6.08";"2d (dihydropyridine analogs)";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(S)=N/CCCN2CCC(c3cccc(OC)c3)CC2)c1";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"13.01";"0.25";"1.81";"7.52";"0";"CHEMBL756251";"Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135029";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2002";"CHEMBL3307551";"";"";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4.0";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"VERAPAMIL";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL4128926";"";"None";"583.78";"2";"5.76";"1j";"CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"16.93";"0.34";"4.13";"7.88";"0";"CHEMBL4121491";"Displacement of [125I]peptide YY from human Y1 receptor after 120 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118122";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1539256";"";"None";"496.63";"0";"4.02";"SID14739373";"COc1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2CCCN2CCCCC2)c(OC)c1";"IC50";"'='";"7623.0";"nM";"5.12";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1426896";"";"None";"426.47";"0";"4.39";"SID22405491";"C/C=C(/C)C(=O)O[C@@H]1c2c(ccc3ccc(=O)oc23)O[C@@H]1C(C)(C)OC(=O)/C(C)=C\C";"IC50";"'='";"5853.0";"nM";"5.23";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613956";"PUBCHEM_BIOASSAY: Dose response counterscreen for neuropeptide Y receptor Y2 (NPY-Y2): Cell-based high throughput assay to measure NPY-Y1 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 1256, 793, 1257 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL7568";"QUINACRINE";"2.0";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL531";"PERGOLIDE";"4.0";"314.50";"0";"4.27";"21";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2108139";"POVIDONE";"4.0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL84";"TOPOTECAN";"4.0";"421.45";"0";"1.85";"TOPOTECAN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL157138";"LISURIDE";"4.0";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"ZAPRINAST";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL917";"FLOXURIDINE";"4.0";"246.19";"0";"-1.68";"SID549426";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL31";"GATIFLOXACIN";"4.0";"375.40";"0";"1.98";"GATIFLOXACIN";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL155048";"";"None";"597.85";"2";"6.82";"6e";"CC(C)c1cc(C(C)C)c(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cc4ccccc4s3)CC2)c(C(C)C)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750756";"Human Neuropeptide Y1 receptor binding affinity";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL242273";"SAFROLE";"-1.0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"LORATADINE";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1679";"LEUCOVORIN";"4.0";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200559";"LACTIC ACID";"4.0";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1609697";"";"None";"479.56";"0";"3.49";"SID14725751";"O=C(NC1CCCCC1)C(c1ccncc1)N(Cc1ccc2c(c1)OCO2)C(=O)c1cnsn1";"IC50";"'='";"32170.0";"nM";"4.49";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614277";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y1 (NPY-Y1). (Class of assay: confirmatory) [Related pubchem assays: 1040, 1255, 1254 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL332347";"";"None";"473.58";"0";"2.38";"BIBP-3226";"NC(N)=NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"17.01";"0.31";"5.68";"5.64";"0";"CHEMBL1101404";"Inhibition of neuropeptide Y1 receptor in human SK-N-MC cells after 60 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153738";"1";"Scientific Literature";"J Nat Prod";"2009";"CHEMBL3307551";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"Mannitol";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1431";"METFORMIN";"4.0";"129.17";"0";"-1.03";"METFORMIN";"CN(C)C(=N)NC(=N)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL42686";"";"None";"500.60";"2";"1.91";"14 (R)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](C(N)=O)c1ccccc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.23";"0.21";"3.71";"3.44";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL40475";"";"None";"566.53";"1";"4.85";"30";"N=C(N)NCCCC(NC(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCCc2ccccc2C1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL692301";"NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay.";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3308090";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1372";"OXIGLUTATIONE";"4.0";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL48493";"";"None";"587.23";"2";"8.77";"2g";"CCCCCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"12.16";"0.24";"-1.63";"8.37";"0";"CHEMBL756252";"Binding affinity against human recombinant NPY Y1 receptor in CHO/dhFr- cell membranes using [125I]PYY";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL487894";"DIPYRONE SODIUM";"None";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"None";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL11359";"CISPLATIN";"4.0";"300.05";"None";"None";"CISPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL495778";"PENICILLIC ACID";"None";"170.16";"0";"0.34";"PENICILLIC ACID";"C=C(C)C1(O)OC(=O)C=C1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1103";"FURAZOLIDONE";"4.0";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4.0";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL157548";"DANOFLOXACIN";"-1.0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1873703";"DIELDRIN";"2.0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1902627";"CLORPRENALINE";"-1.0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL41457";"";"None";"492.02";"0";"3.54";"25";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)NCc1ccccc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.76";"0.26";"3.23";"5.64";"0";"CHEMBL756255";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 1 in SK-N-MC cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"CHEMBL3307551";"";"";""
"CHEMBL4786911";"";"None";"794.63";"2";"2.23";"60";"N/C(=N/C(=O)NCCNC(=O)CBr)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.06166";"nM";"10.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4765023";"";"None";"791.83";"2";"3.08";"75";"N/C(=N/C(=O)NCCNC(=O)Cc1ccccc1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"95.5";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4746354";"";"None";"867.93";"2";"4.67";"76";"N/C(=N/C(=O)NCCNC(=O)C(c1ccccc1)c1ccccc1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"524.81";"nM";"6.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL1909071";"";"None";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL497569";"";"None";"395.46";"0";"4.90";"5m";"O=C1OC2(CCN(c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001158";"Binding affinity to NPY Y1 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1110";"ALOSETRON";"4.0";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"PACLITAXEL";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"Hydroxyurea";"NC(=O)NO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL84158";"TIAPRIDE";"3.0";"328.43";"0";"1.17";"TIAPRIDE";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL398782";"";"None";"523.05";"2";"5.48";"28";"CN(C)CCNC(=O)c1cc(Oc2ccc(Cl)cc2)c2c(c1)c1ccccc1n2C[C@@H]1CCNC[C@H]1F";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.96";"0.27";"1.82";"12.47";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL239568";"";"None";"602.18";"2";"5.43";"19";"CN1CCN(C(=O)c2cc(Oc3ccc(Cl)cc3)c3c(c2)c2ccccc2n3CC2CCN(CC(=O)N(C)C)CC2)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.04";"0.25";"2.42";"12.82";"0";"CHEMBL885426";"Displacement of [125]peptide YY from human recombinant Y1 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138429";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"CHEMBL3308072";"";"";""
"CHEMBL412378";"";"None";"1991.34";"None";"None";"9";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"279.0";"nM";"6.55";"";"";"UO_0000065";"3.29";"None";"None";"None";"0";"CHEMBL755163";"Affinity against Neuropeptide Y receptor Y1 in SK-N-MC cell line";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"CHEMBL3307551";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"2";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"ROSIGLITAZONE";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"BENZBROMARONE";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL820";"BUSULFAN";"4.0";"246.31";"0";"-0.28";"SID67633";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"None";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"DEXAMETHASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1388";"MONOBENZONE";"4.0";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"PROCAINAMIDE";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL4";"OFLOXACIN";"4.0";"361.37";"0";"1.54";"OFLOXACIN";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1130";"DOXIFLURIDINE";"3.0";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL141343";"";"None";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL897";"PROBENECID";"4.0";"285.37";"0";"2.20";"PROBENECID";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL187399";"";"None";"586.69";"1";"4.36";"6e";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3C#N)CC2)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.53";"0.27";"4.16";"5.75";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL77333";"";"None";"374.44";"1";"5.17";"46";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc2oc3ccccc3c2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL748122";"Inhibitory activity tested against Human Neuropeptide Y1 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL558551";"";"None";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL187491";"";"None";"575.71";"1";"4.80";"6c";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(NC(=O)NCCNC2CCN(c3ccccc3C)CC2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.59";"0.27";"3.60";"6.74";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL188576";"";"None";"630.71";"2";"4.11";"3b";"COC(=O)C1=C(C)N=C(C)/C(=C(/O)OC)C1c1cccc(N/C(=N/CCNC2CCN(c3ccccc3[N+](=O)[O-])CC2)NC#N)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.32";"0.25";"4.29";"4.50";"0";"CHEMBL827935";"Inhibition of binding of [125I]PYY to membranes of SK-N-MC cells expressing the human Y1 receptors";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138714";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"CHEMBL3307551";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"IC50";"'='";"1.698";"nM";"8.77";"";"";"UO_0000065";"14.34";"0.27";"6.72";"4.65";"0";"CHEMBL3750350";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 1 min by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL511460";"";"None";"544.66";"2";"2.74";"5";"CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.2399";"nM";"9.62";"";"";"UO_0000065";"17.66";"0.33";"6.88";"6.09";"0";"CHEMBL3750351";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 2 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"IC50";"'='";"0.871";"nM";"9.06";"";"";"UO_0000065";"14.81";"0.27";"7.01";"4.80";"0";"CHEMBL3750351";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 2 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.1259";"nM";"9.90";"";"";"UO_0000065";"16.43";"0.31";"7.62";"5.37";"0";"CHEMBL3750353";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746851";"";"None";"725.73";"2";"2.05";"33";"Cn1cc(CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)nn1.O=C(O)C(F)(F)F";"IC50";"'='";"0.195";"nM";"9.71";"";"";"UO_0000065";"15.87";"0.29";"7.66";"5.15";"0";"CHEMBL3750354";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 15 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL1489";"AZACITIDINE";"4.0";"244.21";"0";"-3.17";"AZACITIDINE";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"SLP";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL850";"SPARFLOXACIN";"4.0";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL175";"DEXIBUPROFEN";"4.0";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1670";"MITOTANE";"4.0";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL267648";"PEFLOXACIN";"4.0";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4.0";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL2397294";"";"None";"378.52";"0";"3.57";"13";"CCOc1cccc(C2(N3CCN(c4cccnn4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"4380.0";"nM";"5.36";"";"";"UO_0000065";"14.16";"0.26";"1.79";"12.92";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL1630579";"MYRTECAINE";"2.0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL975";"MESNA";"4.0";"164.18";"0";"-0.20";"mesna";"O=S(=O)([O-])CCS.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL48950";"";"None";"545.15";"2";"7.60";"2d";"CCCCOc1cc(CCc2nc(C)c(CC)s2)nc(NCc2cc(Cl)cc(NC(=O)OC(C)C)c2)c1";"IC50";"";"";"nM";"";"";"Not Determined";"UO_0000065";"";"";"";"";"0";"CHEMBL656712";"Inhibitory concentration against 1 nM NPY induced [Ca2+] increase in CHO/dhFr- cells expressing recombinant human Y1 receptor; d=Not determined";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149225";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL2397300";"";"None";"390.57";"0";"4.77";"3";"CCOc1cccc(C2(N3CCN(Cc4ccccc4)CC3)C3CC(C)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397299";"";"None";"376.54";"0";"4.78";"2";"CCOc1cccc(C2(N3CCN(c4ccccc4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"19.14";"0.35";"2.43";"45.88";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"salbutamol";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL374478";"RIFAMPIN";"4.0";"822.95";"3";"4.34";"Rifampicin (Rifampin)";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"Raloxifene";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1430";"PENICILLAMINE";"4.0";"149.21";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL325372";"METHYLPARABEN";"-1.0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"LIDOCAINE";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL447";"SECOBARBITAL";"4.0";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1489254";"TRIACETIN";"2.0";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL488025";"EXISULIND";"3.0";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL21";"SULFANILAMIDE";"4.0";"172.21";"0";"-0.08";"SULFANILAMIDE";"Nc1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4.0";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"None";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"RISPERIDONE";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4.0";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL16068";"BROMOBENZENE";"None";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL37161";"FENBENDAZOLE";"2.0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"IBUPROFEN";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL659";"GALANTAMINE";"4.0";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL63323";"NIFLUMIC ACID";"2.0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4.0";"302.46";"0";"4.27";"17-METHYLTESTOSTERONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1544";"LIOTHYRONINE";"4.0";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL98350";"LY-294002";"-1.0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1149";"LEVOCARNITINE";"4.0";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"2.0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL1411979";"METHAPYRILENE";"4.0";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL32749";"FERULATE";"-1.0";"194.19";"0";"1.50";"FERULIC ACID";"COc1cc(/C=C/C(=O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"FLUOXETINE";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL427216";"GLICLAZIDE";"4.0";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3039597";"GENTAMICIN";"4.0";"1390.73";"None";"None";"Gentamycin";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL540445";"PARTHENOLIDE";"2.0";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4.0";"296.41";"0";"3.61";"ETHINYLESTRADIOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL64894";"GENTIAN VIOLET";"4.0";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL417";"EPIRUBICIN";"4.0";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"Emetine";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL264374";"BEZAFIBRATE";"4.0";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL572";"NITROFURANTOIN";"4.0";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL429023";"ROTENONE";"None";"394.42";"0";"3.70";"ROTENONE";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.24";"0.30";"7.75";"5.35";"0";"CHEMBL3750356";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 30 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL60889";"MOSAPRIDE";"3.0";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909175";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"SK-N-MC";"Membrane";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3307551";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"2.754";"nM";"8.56";"";"";"UO_0000065";"14.20";"0.27";"6.28";"4.65";"0";"CHEMBL3750349";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 secs by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL508974";"";"None";"602.69";"2";"2.28";"6";"CCOC(=O)CNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'='";"0.05012";"nM";"10.30";"";"";"UO_0000065";"17.09";"0.32";"8.02";"5.59";"0";"CHEMBL3750356";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 30 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL4751668";"";"None";"783.85";"2";"3.42";"71";"N/C(=N/C(=O)NCCNC(=O)C1CCCCC1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"30.9";"nM";"7.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4764296";"";"None";"795.79";"2";"3.29";"74";"N/C(=N/C(=O)NCCNC(=O)c1ccc(F)cc1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"16.22";"nM";"7.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4445077";"";"None";"1704.02";"None";"None";"(S,S)-9";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C/C=C\C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"IC50";"'='";"489.78";"nM";"6.31";"";"";"UO_0000065";"3.70";"None";"None";"None";"0";"CHEMBL4426106";"Agonist activity at GFP-tagged neuropeptide Y1R (unknown origin) expressed in HEK293T cells assessed as beta-arrestin2 recruitment measured after 60 mins by H33342 staining-based imaging method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425111";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4281479";"";"None";"4310.81";"None";"None";"PYY(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4436741";"";"None";"1736.06";"None";"None";"(S,S)-12";"COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC";"IC50";"'='";"234.42";"nM";"6.63";"";"";"UO_0000065";"3.82";"None";"None";"None";"0";"CHEMBL4426106";"Agonist activity at GFP-tagged neuropeptide Y1R (unknown origin) expressed in HEK293T cells assessed as beta-arrestin2 recruitment measured after 60 mins by H33342 staining-based imaging method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425111";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4748874";"";"None";"5280.93";"None";"None";"EP45";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4751466";"";"None";"5197.82";"None";"None";"GEP44";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"2.399";"nM";"8.62";"";"";"UO_0000065";"14.00";"0.26";"6.37";"4.61";"0";"CHEMBL3750349";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 10 secs by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL3746386";"";"None";"843.78";"2";"2.25";"38; UR-MK299";"CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"0.1288";"nM";"9.89";"";"";"UO_0000065";"16.06";"0.30";"7.64";"5.29";"0";"CHEMBL3750355";"Antagonist activity at NPY1R in human HEL cells assessed as inhibition of 10 nM pNPY-induced Ca+2 response preincubated for 20 mins by Fura-2 dye based spectrofluorimetric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745603";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3308090";"";"";""
"CHEMBL4796216";"";"None";"4384.87";"None";"None";"EP-38";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4752195";"";"None";"6190.04";"None";"None";"EP50";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"2.31";"None";"None";"None";"0";"CHEMBL2394945";"Binding affinity to human neuropeptide Y receptor type 1 by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390830";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL2397298";"";"None";"407.56";"0";"4.18";"17";"CCOc1cccc(C2(N3CCN(c4cccc(OC)n4)CC3)C3CC(C)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL2397295";"";"None";"377.53";"0";"4.17";"14";"CCOc1cccc(C2(N3CCN(c4cccnc4)CC3)C3CC(C)CC32)c1";"IC50";"'='";"892.0";"nM";"6.05";"";"";"UO_0000065";"16.02";"0.30";"1.88";"21.15";"0";"CHEMBL2400739";"Displacement of [125I]PYY from NPY1 receptor in human SK-N-MC cells after 1 hr by microbeta scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SK-N-MC";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396603";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3307551";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"2.38";"None";"None";"None";"0";"CHEMBL2394999";"Binding affinity to human neuropeptide Y1 receptor by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390917";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL4749279";"";"None";"5223.88";"None";"None";"EP44";"CC[C@H](C)[C@H](NC(=O)C(Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4741000";"";"None";"4925.58";"None";"None";"EP40";"CC[C@H](C)[C@H](NC(=O)C(Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4456247";"";"None";"1706.04";"None";"None";"(R,R)-1";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](N)CCCC[C@@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O";"IC50";"'='";"363.08";"nM";"6.44";"";"";"UO_0000065";"3.77";"None";"None";"None";"0";"CHEMBL4426106";"Agonist activity at GFP-tagged neuropeptide Y1R (unknown origin) expressed in HEK293T cells assessed as beta-arrestin2 recruitment measured after 60 mins by H33342 staining-based imaging method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425111";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4759334";"";"None";"5834.64";"None";"None";"EP46";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4755692";"";"None";"743.78";"2";"2.49";"66";"CC(C)C(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.06607";"nM";"10.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4789673";"";"None";"808.65";"2";"2.62";"65";"N/C(=N/C(=O)NCCNC(=O)CCBr)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.4074";"nM";"9.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4752935";"";"None";"730.74";"2";"0.79";"61";"NCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.2818";"nM";"9.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4756494";"";"None";"757.81";"2";"2.88";"67";"CC(C)(C)C(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"14.45";"nM";"7.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4755079";"";"None";"769.82";"2";"3.03";"70";"N/C(=N/C(=O)NCCNC(=O)C1CCCC1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"7.586";"nM";"8.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL4750988";"";"None";"797.88";"2";"3.81";"72";"N/C(=N/C(=O)NCCNC(=O)CC1CCCCC1)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"457.09";"nM";"6.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
"CHEMBL439904";"";"None";"4049.53";"None";"None";"PYY3-36";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713466";"Agonist activity at human NPY1R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4798118";"";"None";"731.73";"2";"0.83";"62";"N/C(=N/C(=O)NCCNC(=O)CO)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"0.0912";"nM";"10.04";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4699851";"Antagonist activity at Y1 receptor in human HEL cells assessed as reduction in pNPY-induced calcium mobilization preincubated for 15 mins followed by pNPY stimulation and measured immediately by Fura-2 dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEL";"None";"";"";"";"CHEMBL4777";"Neuropeptide Y receptor type 1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699401";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"TIME = 0.25 hr";"ANTAGONIST";""
